Kura Oncology is a biopharmaceutical company dedicated to discovering and developing innovative cancer therapies. Through cutting-edge research and a focus on precision medicine, Kura Oncology aims to revolutionize cancer treatment and improve patient outcomes.

Senior Medical Science Liaison - Southeast

Dir/Senior Director, Trade & Patient Access Operations

AD/Director, Marketing Promotions

Associate Director/Director, Biostatistician

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Reporting to the Vice President of Regulatory Affairs, the Associate Director, Regulatory Operations is a hands-on role responsible for the management and oversight of regulatory submissions, systems, and associated procedures. This role interfaces with external publishing vendor(s) for the preparation of submissions, and internal stakeholders to provide operational oversight and support for eCTD regulatory submission activities. Additionally, the position supports the tracking and archiving of regulatory submissions and health authority correspondence, as well as the management and implementation of regulatory systems and tools. This role is critical to building and continuously improving processes to make regulatory operations best-in-class. Essential Job Functions Direct all regulatory submissions management activities, including submission content and timeline planning and coordination of dossier compilation and QC review to ensure submission quality and compliance for health authority acceptance. Act as submission manager for applications and represent Regulatory Operations on relevant project teams, as needed. Ensure document management tasks are completed in a compliant manner including creation, tracking, storage, and archival of regulatory submissions, correspondence, and other documentation. Manage regulatory records, logs, and databases. Key contact for all enterprise systems related timelines and projects for regulatory information and document management. Serve as business system/process owner, as needed. Oversee the implementation and operation of software and business processes for electronic document and regulatory information management systems (e.g., Veeva RIM), eCTD templates, eCTD publishing tools, and other products as needed (e.g., Veeva PromoMats). Lead the development and implementation of internal procedures, work instructions, and training programs for document and dossier management, archiving, and other processes, as needed. Review and contribute to the creation of standards, templates, and procedures related to regulatory documents, and recommend associated process improvements.&nbsp;Take ownership of building and improving standards, templates, and workflows to create scalable, repeatable processes. Responsible for vendor management, building relationships with business partners and managing budgets and contracts. Provide subject matter expert level strategic insight on regulatory technologies and processes related to registration documents, submission records and associated product data records. Monitor and assess business trends, pending regulations and/or guidance documents for potential regulatory operations impact. Other duties as assigned. Job Requirements BA/BS degree in a science or related field, or equivalent combination of education, experience, and training. 8+ years regulatory operations experience in a biotechnology or pharmaceutical environment with demonstrated ability to present and articulate requirements. Advanced knowledge of regulatory submission requirements, guidelines, and publishing standards, including computer word processing, electronic document management systems, and publishing software. Extensive eCTD filing experience with IND/CTA and NDA stages, including labeling and post-approval promotional materials. Experience managing an outsourced regulatory publishing model is a plus. Experience managing medium to large scale systems (e.g., RIM, EDMS). Experience with Veeva RIM and PromoMats, a plus. Demonstrated ability to facilitate, lead and manage the establishment of procedures. Must be highly detail oriented with the ability to multi-task and shift priorities quickly under tight deadlines with minimal oversight. Drives work independently with ownership and accountability; delivers consistent, high-quality results with minimal oversight. Thrives in a fast-paced, dynamic environment and adapts quickly to shifting priorities. Builds scalable processes and finds better ways of working, always looking to improve efficiency and quality. Strong communicator and collaborator; works effectively across teams and with vendors to keep projects moving. Detail-oriented and organized, with the ability to manage multiple priorities and meet deadlines. #LI-RM1 &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Director, Regulatory Affairs Operations

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Essential Job Functions: The Chief of Staff (COS) to the Chief Commercial Officer (CCO) enables the CCO to work most effectively with internal and external stakeholders, drive strategic priorities, and ensure alignment across teams. This is a strategic and facilitative role that requires a combination of focus and flexibility, as well as a willingness to play an active, behind-the-scenes role. As the CCO’s trusted counsel, the COS must be a highly resourceful individual with strong emotional intelligence, self- motivation, and excellent analytical and communication skills. The role is ideal for someone who connects the dots quickly, is solution-oriented and energized by helping a team deliver results through thoughtful planning, coordination, and execution. Partner with the Chief Commercial Officer to prioritize initiatives, manage complexity, and ensure follow-through on strategic goals Support execution of the commercial strategy by translating high-level priorities into coordinated workplans, timelines, and tracked deliverables Coordinate cross-functional workstreams that enable effective execution of commercial initiatives, ensuring clear communication, stakeholder alignment, and follow-through Organize and manage Commercial Leadership Team meetings and offsites, including agenda setting, content development, logistics, and action-item tracking Lead preparation and development of senior leadership presentations, meeting materials, and internal communications that clearly convey progress, insights, and recommendations Support annual and quarterly planning cycles by gathering inputs, consolidating information, coordinating reviews, and maintaining planning documentation Identify operational risks and issues within commercial activities, escalate concerns appropriately, and track remediation actions to resolution Partner with Alliance Management and company’s co-promotion partner to ensure smooth interactions in brand planning, budget planning and standing steering committees Support goal-setting processes across commercial and ensure quantitative follow-up on progress toward objectives Partner with Finance and HR to support commercial budgeting, headcount planning, and routine performance tracking Maintain effective communication between the CCO and commercial teams by facilitating information flow, clarifying expectations, and ensuring timely updates Provide routine progress updates, operational insights, and synthesized summaries to commercial leadership to support decision-making and coordination Job Specifications: Bachelor’s degree required; advanced degree preferred 8–10+ years in the pharmaceutical or biotechnology industry, with broad experience in strategic roles and a strong understanding of commercial functions Proven experience leading cross-functional strategic and organizational initiatives in a matrixed environment Strong project management and prioritization skills with the ability to manage multiple workstreams across stakeholders Excellent communication skills—written, verbal, and visual—with experience developing materials for senior and executive audiences High emotional intelligence, cultural awareness, and the ability to build trusted relationships across teams and geographies Strong leadership presence and the ability to influence without formal authority Comfortable navigating ambiguity, complexity, and high-stakes environments Willingness to travel up to 30% as needed The base range for a Director is $213,800 - $242,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director, Commercial Chief of Staff

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Director, Regulatory Affairs will be responsible for developing, implementing, and providing guidance on US and global regulatory strategies to support development of Kura’s oncology and hematology portfolio. The individual must possess excellent judgment, organizational and planning skills along with exceptional written and verbal communications. &nbsp;&nbsp; To succeed, the candidate will have a sustained reputation for a values-driven, collaborative, engagement style where integrity and the consideration of our Patients drives decisions and actions.&nbsp; Contribute to the development and implementation of regulatory strategies for assigned projects. Lead and oversee the preparation, submission, approval, and maintenance of regulatory applications (e.g., IND/CTA, NDA/MAA, designation requests, pediatric study plans, etc.). Lead and/or assist in authoring regulatory documents and developing responses to Agency queries; manage submissions in coordination with regulatory operations. Lead and/or assist in the management of regulatory agency communications and interactions, preparation of briefing materials, coordination of rehearsals and minutes. Advise cross-functional development teams on regulatory requirements for development and approval pathways, including potential expedited pathways. Advise cross-functional teams and line management on regulatory risks, considerations, and strategies for program(s). Ensure activities and regulatory submissions are compliant with relevant laws, regulations, and guidances. Provides strategic and technical regulatory input for key product development documents. Perform regulatory research and intelligence to continually inform project teams of the evolving regulatory landscape and to identify changes and potential strategic implications. JOB SPECIFICATIONS: 10+ years pharmaceutical/biotechnology industry experience, 5 plus years of regulatory experience PharmD/MS preferred, or Bachelors degree in life science Experience supporting NDAs and working on post-approval products, drug labeling experience would be great Experience leading IND/CTA submissions for clinical trials Excellent written and spoken communication skills Attention to detail Strong organizational skills Strong interpersonal skills Solid working knowledge of drug development process Experience with planning and managing IND/CTA submissions. Experience working and interacting directly with FDA and/or other agencies Good understanding of US and EU regulatory landscape Hematology/Oncology or orphan-drug experience are preferred Demonstrated ability to think critically and analyze scientific information while paying close attention to detail The ability to influence and negotiate professionally at various levels within the project team and with external partners &nbsp; The base range for this role at the Director level is $226,495 - $258,817 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director, Regulatory Affairs

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Essential Job Functions Kura Oncology is seeking a highly motivated Senior Scientist to join our Precision Medicine team and play a pivotal role in advancing our biomarker and companion diagnostic (CDx) testing programs across our oncology pipeline. This position will manage the operational and scientific aspects of diagnostic development, including assay validation, vendor oversight, regulatory preparation, and clinical trial integration. The ideal candidate will bring experience in diagnostic assay development, biomarker operations, and regulatory submissions and will thrive in a collaborative, fast-paced biotech environment where bold science meets strategic execution. Biomarker and Diagnostic Plan Implementation Lead the execution of Companion Diagnostic (CDx) programs in alignment with drug development timelines. Drive operational readiness for global diagnostic development including U.S., EU IVDR, and Japan PMDA pathways. Maintain diagnostic vendor oversight for CDx development, central biomarker testing for patient enrollment, and ctDNA analysis. Author biomarker and diagnostic sections of clinical trial protocols, ICFs, and biomarker management plans, aligning diagnostic implementation with precision medicine strategy. Collaborate cross-functionally with Clinical Development, Regulatory, and Clinical Operations, external partners to align biomarker/CDx strategy to global registration pathways (FDA, IVDR, PMDA). Technical &amp; Scientific Oversight Provide scientific and technical expertise in NGS, PCR, ctDNA, MRD detection, and emerging diagnostic platforms. Oversee and interpret assay validation studies, troubleshoot technical challenges, and ensure assay readiness for clinical and regulatory use. Contribute to biomarker data analysis and interpretation in partnership with bioinformatics and translational research teams. Identify opportunities to integrate ctDNA and MRD testing across programs to strengthen patient selection and monitoring. External Partnerships Serve as the technical point of contact for diagnostic partners, CROs, and assay vendors. Ensure testing compliance with GCP, CLIA, CAP, FDA CDx guidance, and IVDR requirements. Facilitate data and sample transfers for regulatory submissions and clinical validation activities. Job Requirements Ph.D. (or M.S. with equivalent experience) in Molecular Biology, Pathology, Genomics, Biomedical Sciences, or related field. PhD with 5+ years of industry experience or MS with 8+ years with biomarker testing and diagnostic development in pharma/biotech setting, preferably in oncology or Precision medicine. Strong understanding of IVD/CDx development lifecycle, including analytical and clinical validation and regulatory frameworks (FDA, IVDR, PMDA). Hands-on or oversight experience with NGS-based assays, ctDNA testing, IHC, or other molecular diagnostic platforms. Experience in clinical trial documentation authoring, sample management logistics, and diagnostic lab operations. Proven ability to work cross-functionally in a fast-paced, collaborative biotech environment. Strong written and verbal communication skills; ability to clearly interpret and present complex scientific and operational data. The hourly rate for a Senior Scientist Contractor is $100-$120 per hour. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training.&nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Scientist, Precision Medicine - Contractor

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.The Scientist will support the Precision Medicine Team to execute biomarker studies across Phase 1 through Phase 3 clinical trials to generate high-quality biomarker data that supports clinical development for multiple programs. The Precision Medicine Team is responsible for the design and execution of the diagnostic and biomarker strategy for oncology drug development within a highly matrixed organization. Working under the guidance of senior team members, the Scientist will collaborate closely with other internal colleagues in Clinical Development, Clinical Operations, Data Sciences to execute the biomarker sample and data analysis plans. The ideal candidate has strong organizational skills to support more than one clinical study and the ability to communicate and follow up with internal collaborators to ensure the Precision Medicine needs are met in a timely manner. ESSENTIAL JOB FUNCTION Serve as a member of the Precision Medicine team to support biomarker research across multiple Phase 1 to Phase 3 clinical trials for oncology drug development. Provide day-to-day troubleshooting for biomarker sample collection, processing, and testing by working directly with cross-functional teams to ensure timely and accurate delivery of biomarker data. Build and manage internal trackers and dashboards that link sample metrics, clinical trial data, and biomarker test results that ensures data accuracy, consistency, and timely updates for use by the Precision Medicine Team. Collaborate with internal stakeholders from Clinical Development, Clinical Operations, and Data Management to ensure Precision Medicine study plans are integrated into new clinical protocols, study databases, and data/sample review plans Partner with internal stakeholders to execute biomarker data transfer agreements with external vendors, following up on data delivery status, and escalating issues to senior Precision Medicine stakeholders when challenges are not resolved in a timely manner. Contribute to the analysis of genetic and protein biomarker data from clinical trial samples to support Precision Medicine studies Job Requirements PhD in molecular biology, cancer biology, genetics, genomics, bioinformatics, immunology, or related life sciences field. 0–3 years of relevant experience; industry experience not required. Detail oriented, proactive, and interested in building expertise in clinical biomarkers and precision medicine. Demonstrates sound judgment to recognize when issues can be resolved through continued collaboration and when unresolved risks or delays should be escalated to more senior members of the Precision Medicine team. Hands-on research experience involving genomic, transcriptomic, or proteomic data analysis. Proficiency in Microsoft Excel (advanced formulas, pivot tables, data reconciliation). Experience creating data summaries, dashboards, or visualizations (e.g., Excel, Power BI, Tableau, or R). Experience working with large datasets using tools such as R, Python, or similar analytical software a plus. Experience managing complex datasets during graduate or postdoctoral research. The base range for a Scientist is $121,551- $137,270 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1 &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Scientist, Precision Medicine

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Essential Job Functions The Associate Director/Director of Clinical Pharmacology will be responsible for developing, driving, and implementing nonclinical and clinical ADME strategies. You will be a core member of program teams providing ADME perspectives and delivering modeling and analyses necessary to evaluate nonclinical and clinical options, enable plans, and optimize development programs. This includes gap analysis, study design, PKPD analysis and modeling, program assessment, and collaborations to help execute programs. The successful candidate will bring extensive experience in nonclinical and clinical ADME with the ability to work cross-functionally with multifunctional teams to drive programs to success. Provides clinical pharmacology leadership on multi-disciplinary teams for oncology programs including modeling &amp; simulation to satisfy world-wide regulatory requirements. Provides clinical and nonclinical pharmacokinetic expertise to projects including study design, data analysis and interpretation. Develop population PK, exposure-response, mechanistic PK/PD, PBPK and QSP models, as needed, to evaluate risk/benefit and facilitate drug development decisions. Experience in developing clinical pharmacology and nonclinical strategy and execute studies such as but not limited to drug-drug interaction studies, specific population, BA/BE, and food effect. Provides clinical pharmacology support and leadership in preparation of various regulatory documents including study protocol, CSR, Investigator's Brochure, Clinical Pharmacology section of INDs, CTAs, BLAs and/or NDAs, and clinical pharmacology section of package inserts. Participate in meetings with regulatory agencies and respond to regulatory queries. Job Requirements Ph.D. in Pharmacokinetics, Pharmaceutical Sciences, or a closely related discipline with 5+ years of experience for Associate Director or 8+ years of experience for Director in clinical pharmacology, modeling &amp; simulation, drug metabolism and/or pharmacokinetics within a large pharma and / or biotech companies Experience with nonclinical and clinical pharmacokinetic protocol design with experience working with CRO's is required. Experience in Model Informed Drug Development. Strong organizational and time-management skills including the ability to manage several projects simultaneously. A strong entrepreneurial spirit and a desire to be hands on. Strong analytical and critical thinking skills, and attention to details. Demonstrated creativity in problem solving. Ability to effectively collaborate as part of cross-functional teams and with research partners. Excellent professional interpersonal skills, particularly oral and written communication skills and be able to work in a multidisciplinary team environment. Extensive knowledge of regulatory/guidance requirements (i.e. GLP, FDA, EMA) best practices pharmacokinetic/pharmacodynamic testing and risk assessment based on target indication. The base range for an Associate Director is $172,000- $203,000 and a Director is $228,405 - $260,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Director/Director, Clinical Pharmacology

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.We are seeking an experienced and strategic Associate Director/Director of Pharmacovigilance Operations to lead and evolve our global PV operational infrastructure. This is a high-impact role for someone with strong operational acumen and experience managing outsourced PV models in a biotech or fast-paced pharma environment. This role is accountable for the oversight of all outsourced safety operations, vendor governance, and operational compliance across clinical and post-marketing settings. The Associate Director/Director, PV Operations will play a critical role in scaling PV operations capabilities, ensuring inspection readiness, regulatory compliance, and contributing to strategic safety planning as the company transitions through late-phase development and into commercialization. The ideal candidate has experience supporting both clinical and post-marketing programs and can lead vendor governance, inspection readiness, and PV systems management. This role will support the Pharmacovigilance department and report to the Executive Director of Pharmacovigilance and Drug safety. Key responsibilities of the role include, but not limited to: &nbsp;JOB FUNCTION: Oversee the process for ICSR collection, processing, reconciliation, and reporting, including associated quality activities to ensure regulatory timelines and global standards are met. Provide oversight and support of the PV vendor activities, including establishing and monitoring key performance indicators (KPIs), always ensuring inspection-readiness. Oversee global compliance with pharmacovigilance regulations, including timely ICSR submissions, quality case processing, and aggregate reporting support Oversee the lifecycle of PV operational SOPs, work instructions, and guidance documents, providing oversight to the PV vendor and CROs supporting PV activities. Support in the development and maintenance of Safety Management Plans (SMPs) and Pharmacovigilance Agreements (PVAs), with license partners and/or other parties. Support reconciliation activities between safety and clinical databases, as well as partner case exchanges.&nbsp; Support safety database configuration and maintenance, as required. Support PV audit and inspection activities, as required, and serve as SME during these activities. Oversee deviation and Corrective and Preventive Action (CAPA) activities related to, but not limited to, expedited and periodic reporting activities, as well as deviations related to case management processes, as defined in the SMPs or SOPs. Collaborate with Clinical Operations to deliver safety communications to sites and ethics committees. Assist with PV processes and initiatives, representing PV in collaboration with other functions as needed. Work cross-functionally with Regulatory Affairs, Clinical Operations, Clinical Development, Data Management, Quality Assurance, and Medical Affairs to ensure appropriate PV processes are in place and adhered to. Serves as key point of contact between PV and the CROs regarding PV operation management. Provide PV operational expertise in development of RMPs, REMS, DSURs, PSURs, and other safety deliverables. Represent PV operations in internal safety governance forums and external collaborations/partnerships Participate in cross-functional monitoring of study data, as necessary. Assist in the development, review and management of departmental budget, MSAs, SOWs, invoices and payment of work performed by vendors. Job Requirements Degree in Life Sciences, Pharmacy, Nursing or related field required. Minimum of 10 years of Pharmacovigilance experience within a pharmaceutical, biotechnology or related environment, with time spent in a leadership/managerial role within PV Operations. Hands-on experience in vendor oversight, including governance, ensuring adherence to KPIs, and managing PVAs/SDEAs. Expertise in managing outsourced PV models and developing vendor oversight frameworks. Experience in pre- and post-marketing Safety, with proven success in biotech or small/mid-sized pharma, ideally in a lean team setting. Experience supporting late-stage clinical programs and regulatory submissions (e.g, NDA/BLA/MAA). In-depth knowledge of monitoring health authority submissions, CAPAs and relationships between vendors. Strong understanding of global PV regulatory requirements and timelines (e.g. FDA, EMA, PMDA, E2B R3, etc) and PV Systems (e.g. Argus, Arisglobal, Vault Safety) required. Experience working with clinical databases preferred. Experience with PV aggregate reports, signal detection, safety surveillance, literature review, from a PV operational perspective, is preferred. Able to work independently, establish work priorities, and execute decisions with minimal guidance. Experience in oncology/hematology is preferred. Ability to interpret related regulatory guidance and problem-solve towards a compliance approach with a background and understanding of industry best practices. Excellent strategic, decision-making and analytical skills. Excellent collaboration and strong written and verbal communication skills are required. The base range for an Associate Director is $169,000 - $203,000 and a Director is $218,000 - $255,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Director/Director, Drug Safety Operations

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Director of Commercial Analytics and Performance Reporting will play an integral role in the successful launch of Kura Oncology’s lead program. &nbsp;This role will lead our Commercial Analytics activities, leveraging data to drive robust analytical insights that inform our most critical business questions. S/he will work with cross-functional partners to identify and prioritize business questions, develop appropriate analytical approaches and frameworks, and generate insights to maximize commercial opportunities. This role is dynamic, fast-paced, highly collaborative, and will require a demonstrated ability to communicate intricate data concepts and drive action among a diverse group of stakeholders through compelling presentations and dashboards. Key Responsibilities: Development and implementation of best-in-class strategies to align advanced analytics and data science initiatives with overall business goals Act as strategic partner to frame, investigate, and answer key business questions related to performance reporting, including executive reporting and interactions with senior commercial leaders. Develop and execute creation of in-house insights-ready reports and dashboards to drive actionable insights from internal and secondary data sources. Lead the evaluation, tracking, and reporting of brand performance metrics and KPIs through compelling weekly, monthly and quarterly presentations with brand and leadership teams Connect insights together to tell a compelling and persuasive story and deliver clear and actionable recommendations. Partner with colleagues to advance the use of data sources and reporting, including I&amp;A, Sales &amp; Marketing, Agency partners, Market access, RWD, etc. Be accountable for continuous improvement and identification/utilization of new capabilities to maximize the competitive advantages of the business Hands-on ability to leverage diverse datasets to identify insights that inform marketing and sales strategies, shape the customer experience, and elevate impact of omnichannel programs. Oversee data quality management process for assigned brand/s with external and internal data providers to ensure timely, accurate and complete patient and specialty pharmacy data. Act as a key “go-to person” for resolving field reporting and data inquiries issues. Expertise in leading vendors/offshore data partners on connecting, integrating, and synthesizing analysis into a meaningful ‘so what’ recommendation Proven ability to act as a strategic partner with the capacity to quickly establish relationships of trust, credibility, and be seen as a partner Ability to identify, prioritize and describe relevant caveats and uncertainties in data, including how they relate to the business question and broader strategic priorities. Provide thought partnership in building and standardizing commercial reporting. JOB SPECIFICATIONS: Bachelor’s Degree (BS/BA) in an analytic discipline - engineering, mathematics, statistics, economics, etc. Master’s degree in a similar field or an MBA preferred. 10+ years of progressive leadership experience in analytics. Strong analytical, coding skills (such as: Python, R, SQL, etc.), MS Excel and PowerPoint skills. Strong knowledge of internal sales data (i.e. SP, field execution, promotional metrics) and third party pharmaceutical sales and script data (DDD, NSP, Xponent, DataView, longitudinal patient data, claims data, etc.) Advanced knowledge and experience developing BI tools for commercial pharma applications (Power BI, Tableau, Qlik, MicroStrategy, etc.) Expertise in data analysis and in building successful strategies using advanced data driven analysis and reporting (next-best action etc) that drive business results. Strong leader with the ability to persuade and influence others, and develop/deliver impactful presentations Excellent organizational skills and the ability to balance multiple demands Excellent communication, presentation and interpersonal skills Proven and successful team player Must be able to meet deadlines, stay organized, and be self-sufficient The base range for a Director is $226,000 - $260,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director, Commercial Analytics and Performance Reporting

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.We’re looking for a Director/Senior Director, Clinical Development (MD) to lead cross-functional clinical teams for the design and conduct of clinical studies.&nbsp; ESSENTIAL JOB FUNCTIONS: Lead cross-functional clinical teams for the design and conduct of oncology studies. Ensure that scientific rigor and innovation drives Kura Oncology’s development strategies. Ensure excellence in both strategy and execution by partnering closely with colleagues in clinical operations, biostatistics, data management, program management and translational medicine. Serve as Medical Monitor of sponsored clinical research and as medical representative to CROs, reference laboratories and other organizations involved in the execution of clinical trials. Responsible for of all clinical regulatory deliverables and other clinical documents associated with the clinical trials under his/her direct responsibility, including protocols, and the clinical portion of INDs, CTAs, investigator brochures, CRF’s, annual IND reports, CSR’s and clinical expert reports, among others. Responsible for the analysis of clinical data, including safety monitoring in collaboration with PV. Participate in site initiation visits and other site visits at clinical center. JOB SPECIFICATIONS: Minimum of 3 years of relevant experience in drug development either in industry (preferred) or in academia. M.D. degree required. Proven track record of strong clinical research skills, including publications. Ability to partner with others to implement innovative development strategies. Experience in precision oncology/hematology. Demonstrated excellence in independently leading and conducting research and ability to evaluate, interpret and present complex scientific data. Demonstrated written and excellent communication and interpersonal skills, with the ability to translate statistical concepts into layman's terms. Strong attention to detail with ability to understand the broader picture and priorities. Must be a dedicated self-starter with a high energy level and ability to achieve results. Must have strong communication and leadership skills-the ability to influence and work successfully with colleagues, customers, and corporate partners. The candidate should have experience in handling multiple projects at a time. Some travel may be required when appropriate. The base range for this role at the Director level is 281,000 - $323,000 and Senior Director level is $341,000 to $387,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director/Senior Director, Clinical Development -Hematology/Oncology

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Key responsibilities include oversight of outsourced data management &amp; EDC activities by service providers, performing and coordinating internal study team data review, and delivery of fit for purpose clinical data in support of study milestones. ESSENTIAL JOB FUNCTIONS: Provide clear, consistent communication to Kura’s CROs and 3rd party Vendors with respect to data management deliverables and monitor performance against communicated expectations. Coordinate internal team review and feedback during EDC builds and/or migrations and provide clear guidance to external DM and EDC build team throughout. Accountable for DM task and milestone timelines Responsible for ensuring data quality and integrity for clinical study data collection activities. Work with clinical team to define and maintain the Kura Comprehensive Data Review Plan. Lead Kura study team in the review of clinical study data per Comprehensive Data Review Plan. Prepare and provide internal data listings and reports as required. Review protocols for data collection and management feasibility. Provide leadership to the study team with respect to data management activities throughout the study lifecycle: planning, start-up, conduct, close-out. Accountable for the creation and delivery of DM documentation (i.e., eCRFs, CCGs, DMP, Data Transfer Specifications, etc.); ensure documentation is appropriately filed within the Trial Management File (TMF). Review study budgets and provide input on data collection, cleaning, and reporting as it relates to development of vendor contracts Partner with internal content experts to manage and coordinate data collection/maintenance with external vendors; ensure deliverables are identified and met according to project milestones and program/project objectives. Responsible for tracking and documenting data management decisions. Responsible for initiating and chairing meetings associated with assigned studies and initiatives Provide support and contribute to the development of clinical trial timelines as it relates to data management activities. Manage accruals tracking and vendor payments for data management activities. Contribute to the development of departmental procedures documentation. Complete other duties as assigned by the JOB SPECIFICATIONS: A./B.S. degree in Biology, Mathematics, Computer Science or related scientific field. 5+ years’ experience in data management or relevant work in the pharmaceutical/biopharma industry. Experience in oncology strongly preferred. Experience in managing DM activities throughout the study lifecycle (planning, start-up, conduct, close-out) Significant experience providing oversight for database migrations. Experience with an NDA submission desirable Strong project management skills Strong vendor management skills (e.g. Biomarkers, Labs, Imaging, ECG). Able to provide independent DM subject matter expertise to study teams and vendors in defining, managing, &amp; delivering on DM obligations. Experience working in 1 or more EDC platforms (Rave, InForm, etc.). Experience working in a data integration/visualization platform (e.g. Saama, elluminate) desirable Solid understanding of clinical drug development process and knowledge of regulatory requirements and ICH/GCP guidelines. Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects. Excellent interpersonal skills in addition to verbal and written communication skills. Strong Excel skills, SAS experience a plus Flexibility to travel up to approximately 5% of &nbsp; The base range for a Manager is $150,000 - $180,000 and for a Senior Manager it's $178,000 - $213,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Manager/Senior Manager, Clinical Data Sciences

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Partner with the SVP of IR and Corp Affairs as well as the Senior Director, Corporate Communications to develop and execute Kura’s communications strategies and tactics to amplify our story and advance our reputation Support product communications in collaboration with clinical and commercial teams Partners with Commercial to manage and execute the company’s social media strategies and enhance patient advocacy relationships Partners with Human Resources to assist with internal communications, drive employee engagement and further strengthen corporate culture Support internal communications by drafting articles for the Company intranet and supporting the periodic newsletter distribution Manage corporate social media content and calendar across LinkedIn, X (Twitter), YouTube, and other platforms; track performance analytics Coordinates and maintains a communications calendar Support preparation of investor relations materials, including press releases, conference call scripts and presentations Analyze industry/market trends and perform competitor analysis. Communicate relevant insights to the IR team and leadership Coordinate logistics for investor conferences and events. Manage updates to corporate website to ensure compliance with public disclosure, positioning, key corporate messages, and regulatory requirements Supports community relations and corporate giving efforts and other CSR activities on behalf of the company; creates materials and content to showcase our community efforts externally Coordinates and supports leadership team with media interviews, speaking engagements and participation in investor events Oversee the use of corporate brand standards and style guidelines to ensure quality and uniformity across all communications channels Ensures high quality and timely results for all communications Other duties as requested by supervisor &nbsp; JOB SPECIFICATIONS: Accredited Bachelor’s degree preferably in Communications, English, Journalism or related field Prior experience in biopharmaceutical industry in a corporate or agency role strongly preferred 5+ years of relevant experience in corporate communications or related field Ability to demonstrate strong presence and cultivate relationships with senior leadership team Outstanding interpersonal and communication skills, both written and verbal Interest/knowledge in graphic design and the interplay between user interfaces and experience, copywriting and content strategy Self-starter, able to work well as a member of a team, but also work independently with limited oversight Track record of managing issues and ability to stay calm under pressure Strong project management skills and a history of driving projects to completion in a fast-paced environment General working knowledge of essential computer applications (i.e. MS Word, Excel, PowerPoint, CRM) Ability to influence others Ability to multi-task The base range for a Manager is $145,000 - $168,000 and a Senior Manager is $175,000 - $220,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Manager/Sr. Manager, IR & Corporate Communications

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: General: Responsible for the planning and management of the operational aspects of clinical trials, including CRO and vendor management/oversight, ensuring project milestones and objectives are met and clinical study deliverables are consistent with program/company goals. Collaborate with internal and external team members for the planning and execution of clinical trials. Accountable for coordination of planning, initiation, completion, and reporting of clinical study protocols within or across programs from team endorsement to reporting. Ensure clinical trials meet time, quality, and cost targets consistent with the overall Clinical Development Plan. Lead the development of and provide input into study-related documents, including ICFs, CRFs, monitoring plans, study, lab and pharmacy manuals, data management plans, etc. Also performs review and provides strong operational input in the development of clinical trial protocols and CSRs Contribute to department documentation development, such as the development and writing of Standard Operating Procedures (SOPs). Collaborate with Legal &amp; Clinical Contracting &amp; Outsourcing (and others, as needed) on the development and management of study specific agreements/budgets (i.e., non-disclosure agreements, clinical trial agreements, clinical research organization agreements, etc.). Organize and manage project timelines and budgets; help ensure project deliverables are on time and within budget and amended accordingly. Provides leadership and contributes to all operational aspects of the trial budget, including forecasts to ensure delivery within the business financial standards. Oversee the conduct of studies and ensure studies are implemented according to the study protocols and in compliance with local, ICH, GCP and company policies and procedures. Monitor and visit clinical study sites as needed. Track, collect, and review clinical documentation for clinical trials. Complete other duties as assigned by the manager. Key contributor to the development of annual trial/project objectives and communicating to relevant line management and Clinical Strategy Team (CST). Serves as the key CST point of contact for the trial. Accountable for the successful preparation and presentation of operational content at key leadership discussions (CST, GPT, SLT, etc.). Ensures strong oversight, review, and delivery of trial/project CAPAs in order to meet corporate compliance standards and timelines. Accountable for partnering with CRO in audit responses and addressing quality issues. Filters, prioritizes, analyzes, and validates complex and dynamic information from a diverse range of external and internal sources to respond to technical operational and organizational challenges. Ensures inspection readiness application for all assigned clinical trials. Sr. CTL: Manages projects/work streams with high complexity, risk, impact, and reach. Manages large-sized global clinical teams with members also from outside the direct working environment.&nbsp; Coordinates stakeholders from closely related areas and beyond. Demonstrates skills in successfully leading international teams in the matrix organization and directs, influences, and motivates people; creates and leads a positive working climate.&nbsp; Develop and lead operational and therapeutic area training for internal and external study team members. Directs multiple studies in parallel and/or be called upon for program management duties. Exhibits Subject Matter Expert level understanding of multiple functions and functional processes. Accountable for successful project execution including definition of milestones and clarification of project scope.&nbsp; Receives minimal guidance and works independently.&nbsp; Acts as a senior advisor and mentor within the team and beyond and serves as best practice resource within own discipline or as technical expert on cross functional teams or projects JOB SPECIFICATIONS: Advanced degree desirable; PM certification desirable Ideally 10 years clinical research experience with at least 5 years of direct trial management experience Some experience in oncology preferred. Experience in CRO oversight is required Manages large sized global clinical trial team Works with minimal or no supervision Ability to mentor junior staff Self-directed and proactive handles multiple complex tasks Strong organization, documentation, and communication skills. Excellent interpersonal skills: ability to collaborate across disciplines. Detailed knowledge of GCP, ICH Guidelines and current US FDA regulations. Ability to travel up to approximately 30% of time. Hybrid on-site in Boston two days per week. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Clinical Trial Leader

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Senior Director, Corporate Communications, is a dynamic, experienced leader who, as a critical member of the investor relations and corporate affairs team, will shape our narrative, elevate our brand and build trust across key audiences, with a strong focus on external, product and pipeline communications to support our company’s growth. The successful candidate will develop and implement a comprehensive corporate communications strategy that aligns with the company’s vision, values, and business goals. H/She will ensure information complies with all guidelines and SEC regulations. The ideal candidate will have experience in the biotechnology and/or pharmaceutical industry developing communications campaigns and managing creative brand awareness programs across multiple channels and audiences. This role will report to the Senior Vice President of Investor Relations and Corporate Affairs and have regular interactions with the executive team including the Chief Executive Officer, Chief Medical Officer, Chief Commercial Officer and other key members of the management team. Responsibilities Manage the development and execution of strategic communications plans and initiatives aligned with our corporate goals to build company awareness with key stakeholders and support the business Collaborate regularly with other functions within the company and outside agencies to elevate key corporate milestones, create compelling storylines to drive media coverage and increase brand awareness Create a comprehensive digital media plan incorporating various platforms (social, web, video), developing creative content and design, ensuring messaging consistency and measuring success; manage Kura Oncology’s social media accounts Draft communications materials, including news releases, Q&amp;A documents, talking points, interview briefs, corporate presentations, social media, website copy and other digital content Design and implement a comprehensive executive thought leadership strategy Collaborate with multiple functions on pipeline milestones and data readouts, develop and manage effective crisis communications Serve as a liaison between the external partner communications team, Finance, Marketing, Commercial, Clinical Development, and BD teams. Coordinate the creation of a unified communication calendar to align efforts, key dates, and messages across departments. JOB SPECIFICATIONS: Bachelor’s or advanced graduate degree a related discipline. 10 + years in the biotech/pharmaceutical industry or public relations agency. Direct experience leading Corporate Communications at a public biopharma company or agency. Strong writing skills in a variety of areas, from scientific information to creative writing. Ability to distill scientific information into clear and concise corporate messaging and materials, including press releases and Q&amp;A. Experience in driving results in media relations, digital and social media, and pipeline/product communications. Recognized as an expert and trusted advisor with a proven track record in crafting, executing, and steering top-tier corporate communication strategies and initiatives that yield tangible, measurable outcomes. Excellent interpersonal skills to facilitate interactions with all levels of the organization and manage and lead projects involving cross-functional teams. Strong collaborator that knows how to drive projects forward, meets or exceeds deadlines and can work in a fast-paced environment. Ability to present and express ideas and information clearly and confidently in a manner appropriate to the specified audience, whether verbal or written. Ability to travel periodically as required. The base range for a Senior Director is $265,000 - $300,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Director, Corporate Communications

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTION: Act as the “CEO” for Kura’s lead menin inhibitor, ziftomenib, fostering a sense of mission, creativity and urgency. Lead the Global Program Team: an empowered multi-disciplinary team of leaders Develop near and long-term strategic objectives and recommendations for the asset across all indications from early to late-stage development and ongoing lifecycle management Accountable - the single point of accountability for all Global Program Team activities Define and lead the membership of the core and extended team Focus on full cross-functional business including clinical development, commercial, CMC, finance, and business development Extended partnership with global program management, commercial and development functional leads, external partners, and Senior Leadership Team Work with the team and with senior leaders to define the strategic direction for the asset and plays a key role, driving execution of asset goals, and ensuring alignment and integration among Core Global Program Team and Extended Teams. Form a close partnership with department leads and with program management to build program plans, identify and mitigate risks, capitalize on asset opportunities, manage budgets, and timelines and ensure best practices. Represent the program to internal and external stakeholders, including collaboration partners and the Board of Directors. Lead key program team meetings and serve as a point of escalation for the program to senior leadership. Help build best practices for efficient and effective program teams. Support external stakeholders engagement including Health Authorities, potential strategic partners, vendors and and KOLs. Drive cross-functional collaboration and act as the owner of the Asset Integrated Development Plan Work with corporate affairs on investor communications to optimize external program communications Partner directly with the SVP, Global Program Leadership to lead change and evolution of program and portfolio strategy to enhance decision-making, build high-performing teams, and optimize portfolio decisions across programs &nbsp; JOB SPECIFICATIONS: 15+ years drug development and commercialization experience 10+ years oncology experience, with preference in heme/oncology Prior experience with partnered programs (development and/or commercial) will be valuable Highly visible role focused on cross-functional team leadership, including strategy development, communication and driving tactical delivery of programs Strategy, Project, Program and Portfolio Management, Talent Development, Mentorship and Alliance Management expertise Advanced Degree (MBA, MS, PharmD, PhD) Build trust, transparency, and clear communication plans Connect strategic vision for asset strategy to the competitive environment and company strategy Ability to understand and communicate complex scientific and commercial matters while keeping the big picture in mind and the credibility to engage subject matter experts on details at all levels in the organization Ability to consider and integrate different points of view, new ideas etc.; demonstrates self-awareness and emotional intelligence Thorough understanding of company specific matrix organization, functional impact and regional representation to proactively build the relationships needed to be successful across functions and departments The base range for a Vice President is $333,000 - $368,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Vice President, Global Program Leader

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Kura Oncology’s Translational Research group in San Diego is seeking a motivated, multiskilled bench scientist to support ongoing oncology research programs. The successful candidate will design, execute, and troubleshoot cellular and biochemical assays in a highly collaborative, fast-paced laboratory environment. The candidate should be experienced in standard molecular biology, biochemistry, and mammalian cell culture techniques, and possess strong data interpretation and communication skills. Essential Job Functions Conduct cell-based, genetic, and biochemical experiments to validate drug targets/mechanisms of action Perform and troubleshoot routine assays independently or with limited direction from supervisor Accurately document, analyze, and communicate experimental results, including at internal or cross-functional meetings Work collaboratively with the team to execute CRISPR/genetic screens and other large-scale projects on accelerated timelines Contribute to the development of novel methods/assays as needed to support dynamic research programs Job Requirements Bachelor’s with 4-6+ years' experience or MS degree in molecular/cellular biology/biochemistry or related discipline with 3+ years’ experience. Extensive experience in standard molecular biology/biochemistry techniques (immunoblotting, qPCR). Extensive experience in mammalian cell culture, cell-based assays, and cell line engineering. Proficient in tissue handling techniques such extraction of protein and nucleic acids from cells or tumors. Experience with gene expression tools and techniques (si/shRNA knockdown, CRISPR knockout, overexpression, transient transfection, stable viral transduction, library screening). Comfortable conducting and troubleshooting routine experiments independently while remaining highly organized and detail oriented. Ability to analyze/critically interpret data, generate summary/graphical representations using software such as GraphPad, and communicate results clearly and in a timely fashion. Eagerness to expand scientific and technical knowledge through literature consultation and collaboration with Kura colleagues. Flexibility in schedule, willingness to contribute to a highly motivated and productive team, and ability to adapt quickly to changing needs of the group and company. The base range for an Associate Scientist is $82,255 - $117,270 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1 &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Scientist

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Associate Director/Director of Statistical Programming is responsible for providing technical leadership and programming support to Clinical Development in one or more indications. This individual will collaborate with project biostatisticians, clinical data managers, CRO vendors, and other colleagues in the creation, implementation, and maintenance of statistical programming deliverables for each project. The candidate will support the Head of Statistical Programming to continuously improve processes to conform to evolving industry standards and participate in the ongoing review and development of quality systems and processes, including CDISC implementation and other internal/external initiatives. Provide leadership and support to project teams on all data programming matters according to the projects’ strategies. Communicate regularly with CRO vendors to ensure quality and on-time delivery and with members of various internal teams to provide delivery-related updates. Lead projects for all programming deliverables through the project milestones from study start-up to regulatory submission and approval, and post marketing support. Lead design, development, and validation of CDISC submission packages. Review CRO statistical programming deliverables and perform acceptance check and validation, to ensure adherence to Statistical Analysis Plan, CDISC standards, and submission readiness. Contribute and collaborate across functions for the identification and development of programming standards and macros to facilitate the creation of statistical deliverables, as well as in process improvement activities to ensure high quality and timely statistical programming deliverables. Ensure compliance to internal standards and work with line management to identify resource needs based on project milestones and deliverables. Mentor junior staff with regard to programming techniques, project management, and implementation of standards. Contribute to the recruitment process for programmer positions within the department, both contract and permanent. Act as programming representative in a multidisciplinary study team to ensure timely and quality support for analysis and reporting of clinical trials up to regulatory approval, product launch, and annual reports. Develop data models, programming standards, and codes as well as train end users in the use of project standards to support programming deliverables that follow regulatory submission requirements. Implement quality control procedures that are operationally optimized and in compliance with regulatory requirements. Support department initiatives and task forces. Participate in departmental or cross-functional working groups and process improvement activities. Assist in resource assessments based on in-depth project knowledge, milestones, and deliverables. Implement global resourcing strategy with regard to the use of off-shore operations, outsourcing, and insourcing. Effectively interact with external programming resources, including contributing to development and/or review of contract specifications and feedback on performance. Contribute to the set up and ongoing maintenance of data transfer processes and programming related applications/systems JOB SPECIFICATIONS: Basic Qualifications MS in Statistics, Computer Science, Mathematics, Engineering, Life Science, or related field with 8+ years of programming experience in the pharmaceutical industry, or BS in Statistics, Computer Science, Mathematics, Engineering, Life Science, or related field with 11+ years of programming experience in the pharmaceutical industry. Advanced SAS programming skills in a clinical data environment with expertise in at least one therapeutic area. Extensive knowledge of clinical trial research methodologies, CDISC, ICH, GCP, and 21 CFR Part 11 rules and regulations. Leverage AI and automation tools to enhance efficiency and streamline programming workflows Preferred Qualifications Experience in ad-hoc programming to produce analysis for various analyses in a short timeframe. Thorough understanding of the clinical drug development process (clinical trials Phase I-IV). Knowledge of regulatory requirements concerning electronic submission standards and experience in delivering one or more submissions to regulatory authorities globally. Experience working with all levels of management and consulting with key business stakeholders. An ability to influence greater outcomes. Strong team player that has a customer service approach and is solution oriented. Attention to detail and the ability to work individually, within a multi-disciplinary team, as well as with external partners and vendors. Possesses strong written and verbal communication skills. Experience in Oncology therapeutic area. The base range for this role at the Associate Director level is $195,476 - $220,000 and Director level is $236,245 - $266,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp; #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Assoc Dir/Director, Statistical Programming

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Responsible for leading and developing the clinical drug supply strategy, planning and management of all supply chain activities required to support global Phase I – III clinical studies including forecasting, supply planning, IRT configuration, inventory management and CMO management Collaborate with the Clinical Development and Clinical Operations teams from protocol development through final study design to have an in-depth understanding of the clinical study requirements and assumptions needed to set up the supply chain required to support the execution of the study and develop the IP forecast Participate in Clinical Sub Team (CST) meetings, Study Team meetings, Project Team meetings and present Supply Chain updates as required to the Kura cross-functional team Develop an expert-level understanding of the IRT system used to manage site activation, IP site shipments, monitor patient enrollment, patient visits, determine trends and execute adjustments Manage extensive internal and external touchpoints and maintain close communication and collaboration to ensure adequate clinical drug supply for multiple global clinical trials while ensuring compliance with cGMP and global regulatory requirements Responsible for providing commercial supply chain support in collaboration with the Manufacturing, Quality and the Commercial team including serialization expertise, as well as the release and distribution of commercial product from 3PL to authorized trading partners in compliance with the Drug Supply Chain Security Act (DSCSA) Participate in the creation and maintenance of clinical and commercial SOP’s and Work Instructions and related documentation Lead continuous improvement initiatives in collaboration with the IMSC team, as well as cross-functional partners to document, standardize and streamline core supply chain processes supporting Kura’s clinical programs, as well as the commercial supply chain Support financial planning for global clinical studies including budgeting, forecasting and strategic planning activities Job Specifications: Technical degree or equivalent (BS/MS), preferably in Supply Chain or IT 8-10 years pharmaceutical/biotechnology supply chain planning and forecasting experience, preferably in a manufacturing or commercial environment 3- 5 years of leadership experience in pharmaceutical/biotechnology industry with a proven track record of leading teams and delivering results Experience managing complex global supply chain operations including vendor partnerships, contract negotiations, while ensuring compliance with cGMP regulations and requirements Experience collaborating with Manufacturing, Quality and CMO’s including providing a 12 – 24 month rolling forecast of drug product requirements, managing production schedules and coordinating FG deliveries Comprehensive knowledge of CMC requirement/activities including development, validation, regulatory and quality requirements and timelines The base range for a Director is $202,000 - $235,672 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director, Supply Chain

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.GENERAL JOB FUNCTIONS: The Clinical Trial Associate (CTA) supports the operational execution of clinical trials from start-up through close-out. This role partners closely with Clinical Trial Leaders, study teams, CROs, and vendors to ensure trials are conducted efficiently, compliantly, and in alignment with program and company objectives. Key Responsibilities Support clinical trial operations across all phases of the study lifecycle, ensuring milestones, deliverables, timelines, and budgets are met. Assist with CRO and vendor coordination and oversight, including tracking performance, deliverables, and documentation. Collect, track, and review investigator site regulatory documentation (e.g., FDA Form 1572, FDFs, CVs, medical licenses, and study-specific documents) for completeness and accuracy. Manage Trial Master File (TMF) filing, maintenance, reconciliation, and inspection readiness activities in compliance with ICH-GCP and company SOPs. Track and maintain essential study documentation, including CTA and budget status, site and vendor payments, monitoring visits and reports, SUSARs, CAPAs, and enrollment metrics. Coordinate study team, vendor, and site meetings, including scheduling, agenda preparation, minute-taking, and distribution. Ensure clinical trial management systems (company and/or CRO systems) are kept current in collaboration with the Clinical Trial Leader (CTL). Support study start-up, conduct, monitoring, and close-out activities to ensure protocol adherence and regulatory compliance. Assist with site monitoring activities, audit and inspection preparation, and participate in audit/inspection interviews as required. Support ordering, tracking, and distribution of investigational product and study supplies; assist with IRT oversight and drug inventory tracking. Provide operational and financial support, including purchase orders, contract setup, invoice processing, and tracking of study budgets. Assist with development, review, and maintenance of study documents (e.g., protocols, ICFs, CRFs,&nbsp;monitoring plans, manuals). Sr. CTA: Highly experienced with using different eTMF systems (e.g., Veeva Vault, etc.) Accountable for projects within a clearly defined scope and milestones. Accountable for the quality of own work. Works independently and receives a moderate to low level of guidance or direction within clear or even broad guidelines. Drive harmonization of processes throughout Clinical Operations, use best practices to improve products or services Contribute to mentoring, training and provision of direction and guidance to increase knowledge of new team members / new employees Make process improvement suggestions and develop new process approaches Demonstrate ownership for all assigned tasks and demonstrate a willingness to build knowledge Take on additional tasks as assigned by management Proficient in using and training other CTAs &amp; CTLs on the financial tools / systems to create accurate financial documents Independently execute tasks outlined in the General portion of Essential Job Requirements. Close collaboration with CTA Line Manager to align on new concepts, address resource topics, exchange status updates Responsible for driving and guiding the respective group, while implementing efficient processes, data driven approaches, tools, and training Responsible to conduct and lead CTA trainings and meetings on request Responsible to monitor quality and compliance of CTA implemented processes Role Model and represent / present the CTA Team to Leadership as well as internal / external functions, if needed JOB SPECIFICATIONS: General: Ability to work in a matrix environment Experience working in a high-volume environment while maintaining both organization and the ability to prioritize tasks Good understanding of the responsibilities and needs of other functions in a clinical trial Reliable, conscientious, and confidential Strong interpersonal skills and ability to deal with people at all levels with sensitivity and tact as well as ability to collaborate across Some experience in oncology Experience in CRO oversight is preferred. Strong organization, documentation, and communication skills with an ability to Ability to travel based on assigned study needs, typically minimal travel required. Sr. CTA: Requires a bachelor’s degree in scientific field plus some to substantial relevant professional experience, and good knowledge and experience in clinical trial management or a substantial amount of professional experience in a clinical research-related position (4 years or equivalent) and/ or additional qualifications that also provides exposure to fundamental clinical research related skills &amp; knowledge Ability to mentor and coach junior or new staff Advanced knowledge of medical and trial related terminology Excellent administrative and coordination skills Excellent communication skills – both verbal and written Excellent computer skills including knowledge of MS Office™ (Excel™, Word™, PowerPoint™), Outlook, and TEAMS Excellent oral and written communication in English Excellent time and priority management, ability to work efficiently under pressure Excellent understanding of the policies and procedures of Clinical Operations and of ICH-GCP and current FDA regulations. Highly motivated, shows initiative, is proactive and able to work independently as well as in a team Proficient Trial Master File experience, including use of different eTMF systems Strong organizational and problem-solving skills Willing to take on responsibility and accountability, exhibits Leadership skills The base range for a Senior CTA is $103,000 - $147,900 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1 &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Clinical Trial Associate

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Key responsibilities include oversight of outsourced data management &amp; EDC activities by service providers, performing and coordinating internal study team data review, and delivery of fit for purpose clinical data in support of study milestones. ESSENTIAL JOB FUNCTIONS: Provide clear, consistent communication to Kura’s CROs and 3rd party Vendors with respect to data management deliverables and monitor performance against communicated expectations. Coordinate internal team review and feedback during EDC builds and/or migrations and provide clear guidance to external DM and EDC build team throughout. Accountable for DM task and milestone timelines Responsible for ensuring data quality and integrity for clinical study data collection activities. Work with clinical team to define and maintain the Kura Comprehensive Data Review Plan. Lead Kura study team in the review of clinical study data per Comprehensive Data Review Plan. Prepare and provide internal data listings and reports as required. Review protocols for data collection and management feasibility. Provide leadership to the study team with respect to data management activities throughout the study lifecycle: planning, start-up, conduct, close-out. Accountable for the creation and delivery of DM documentation (i.e., eCRFs, CCGs, DMP, Data Transfer Specifications, etc.); ensure documentation is appropriately filed within the Trial Management File (TMF). Review study budgets and provide input on data collection, cleaning, and reporting as it relates to development of vendor contracts Partner with internal content experts to manage and coordinate data collection/maintenance with external vendors; ensure deliverables are identified and met according to project milestones and program/project objectives. Responsible for tracking and documenting data management decisions. Responsible for initiating and chairing meetings associated with assigned studies and initiatives Provide support and contribute to the development of clinical trial timelines as it relates to data management activities. Manage accruals tracking and vendor payments for data management activities. Contribute to the development of departmental procedures documentation. Complete other duties as assigned by the JOB SPECIFICATIONS: A./B.S. degree in Biology, Mathematics, Computer Science or related scientific field. 5+ years’ experience in data management or relevant work in the pharmaceutical/biopharma industry. Experience in oncology strongly preferred. Experience in managing DM activities throughout the study lifecycle (planning, start-up, conduct, close-out) Significant experience providing oversight for database migrations. Experience with an NDA submission desirable Strong project management skills Strong vendor management skills (e.g. Biomarkers, Labs, Imaging, ECG). Able to provide independent DM subject matter expertise to study teams and vendors in defining, managing, &amp; delivering on DM obligations. Experience working in 1 or more EDC platforms (Rave, InForm, etc.). Experience working in a data integration/visualization platform (e.g. Saama, elluminate) desirable Solid understanding of clinical drug development process and knowledge of regulatory requirements and ICH/GCP guidelines. Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects. Excellent interpersonal skills in addition to verbal and written communication skills. Strong Excel skills, SAS experience a plus Flexibility to travel up to approximately 5% of &nbsp; The base range for a Manager is $157,000 - $179,000 and for a Senior Manager it's $182,000 - $207,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Senior Manager / Associate Director, Financial Planning &amp; Analysis (FP&amp;A) will be a key member of the FP&amp;A team, providing operational planning, analytical insights, and strategic financial support to help Kura achieve its commercial, operational, and long-term financial objectives.This role is responsible for leading core financial planning activities with transparency and rigor, while partnering cross-functionally to provide financial leadership and decision support. The ideal candidate will serve as a trusted advisor to business leaders, translating complex financial data into actionable insights that drive performance and strategic outcomes.The position supports multiple functional areas and plays a critical role in the annual operating plan, monthly and quarterly forecasting, performance reporting, spend management, investment and program analysis, long-range planning, and continuous improvement of FP&amp;A systems and processes. Support and help lead the FP&amp;A function, including long-range planning, annual budgeting, rolling forecasts, and analysis of actual results versus plan. Serve as the FP&amp;A business partner for SG&amp;A functions and selected R&amp;D departments, identifying opportunities for efficiency, cost optimization, and process improvement. Lead the preparation, analysis, and presentation of financial results, forecasts, and outlooks for supported functions on a quarterly and annual basis. Develop a deep understanding of functional operations and resource requirements to effectively challenge assumptions, budgets, and investment requests. Provide timely, accurate, and insightful financial analysis and business context to support operating and strategic decision-making. Critically review and evaluate annual and multi-year budget submissions; documenting issues, communicating findings, and partnering with stakeholders to resolve concerns. Leverage financial systems and tools to analyze and synthesize large data sets into clear, summarized insights for business partners. Contribute to ongoing improvements in FP&amp;A processes, reporting, and systems to enhance scalability and decision support. Perform other duties as assigned. JOB QUALIFICATIONS: Bachelor’s degree in Finance, Accounting, Economics, or a related field. 5+ years of progressive experience in FP&amp;A, corporate finance, or related roles, preferably within a biotech or pharma organization. Hands-on experience with budgeting, forecasting, long-range planning, and variance analysis Strong planning, reporting and analytical skills with demonstrated business and systems proficiency in previous roles. Demonstrated ability to partner effectively with cross-functional stakeholders and support business leaders with financial decision-making. Strong proficiency in financial modeling, forecasting, and preparing external presentations; advanced Excel and PowerPoint skills; experience with financial planning software (e.g. Adaptive Insights, Hyperion) a plus Highly organized and detail-oriented, with the ability to manage multiple priorities in a fast-paced environment. The base range for a Senior Manager is $165,000 - $187,000, for an Associate Director the range is $176,000 - $192,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Sr Mgr/Associate Director, FP&A

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Reporting to the Executive Director of R&amp;D Quality Assurance, the Sr Manager/Associate Director, PV-GCP (Pharmacovigilance-Good Clinical Practice) is primarily responsible for supporting the development and implementation of processes and programs that provide quality and compliance oversight utilizing proactive end to end strategies for pre and post-marketing Pharmacovigilance activities and will provide QA GCP support to assigned clinical development programs.. The incumbent may also be responsible for supporting relevant processes and programs that ensure computer system assurance (CSA) for applicable clinical/PV systems. The incumbent builds collaborative, supportive relationships and serves as a point of contact for Quality Assurance for PV and other relevant departments including clinical development, trial operations, clinical data sciences, and other stakeholders. Supports and maintains a quality-focused culture and mindset across the organization. Develop collaborative partnerships with PV and assigned clinical study teams/study team leaders to maintain a current understanding of potential areas of quality risk exposure within the context of ongoing clinical studies and across clinical programs as assigned. Ensure compliance with pre and most marketing PV requirements, and GCP activities including facilitating and managing internal and external PV/GCP audits/audit programs, as applicable. Implement and support QA activities that foster an outcome of compliance and adherence to relevant laws, regulations, guidance; upholds the rights and welfare of patients; is focused on data integrity and end to end quality assurance Assist in identifying opportunities for process improvement initiatives, including process/program reviews to identify approaches that will prevent quality issue recurrence (e.g. issue escalation and management; and applicable corrective/preventative action programs, periodic internal audit/gap assessment). Assist with the development and tracking of trending and metrics of internal as well as external vendor quality issues. Provide related training on new regulatory requirements and industry practices. Lead and manage PV inspection readiness activities and other key programs as applicable. Support Regulatory Inspections of Kura Oncology products, including supporting/facilitating back room and front room activities and supporting the drafting/reviewing of responses to regulatory authority findings, as applicable. Promote quality and risk management principles (e.g., quality by design, critical to quality focuses, risk assessment and risk ranking, establishment of risk thresholds and tolerance limits) when supporting innovative programs and advancing ongoing clinical programs. Maintain accountability for ensuring risk-based strategies are utilized when managing and mitigating quality issues and supporting clinical studies, ensuring study-specific risk management activities and strategies are utilized consistently across programs. JOB SPECIFICATIONS: BA/BS degree required, advanced degree a For Senior Manager a minimum of 6 years, Associate Director a minimum of 8 years of experience in the bio-pharmaceutical R&amp;D industry with at least 4 years (6 for AD) or more years in a PV/GCP Quality Assurance Pre and post marketing PV experience is required. Minimum 2 years of experience leading teams, projects, programs or direct reports required. Demonstrated experience drafting, reviewing, implementing, and optimizing standard operating procedures (SOPs). Demonstrated knowledge and application of Global regulations and guidance for GVP, and GCP, and an understanding of requirements for validated computerized systems used in clinical trials and PV Experience in the conduct and reporting of internal and external audits, root cause analysis and the translation of findings into corrective actions plans that mitigate risks to study subjects, data integrity and clinical programs. Experience preparing for, participating in, and subsequent response to health authority GVP/GCP inspections/partner audits. Working knowledge of Veeva (or similar QMS e-system) required. Knowledge of Inspection Management Tools a plus. Ability to write clear quality position statements, risk-based audit reports, and procedures. Excellent oral and written communication Strong judgment, project management and decision-making skills; able to manage multiple projects and demanding timelines. Operational Experience (e.g., PV Operations, Clinical Operations, Data Management), work in both clinical and commercial stage organizations; and/or experience as a trainer are an advantage. The base range for this role is $170,000 - $206,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp; #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Manager/Associate Director, Clinical Quality Assurance

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Join us as we embark on an exciting journey in transforming the treatment landscape of acute myeloid leukemia (AML). We are searching for a Director / Senior Director, KOMZIFTI (ziftomenib) Marketing, to report directly to the Executive Director of Marketing. The successful candidate will be responsible for the strategic planning and execution of HCP and Consumer marketing and will aid value and access pull through to support the recent approval of KOMZIFTI in relapsed / refractory (R/R) NPM1-m AML. This role requires strong leadership to strategically drive and cross-functionally integrate across internal and external teams.&nbsp; The ideal candidate will bring deep experience in oncology / hematology marketing, insight-driven planning, and operational excellence. This is a high-visibility role with regular engagement across senior leadership, key decision-makers, and sales, offering the opportunity to make a meaningful impact on the success of KOMZIFTI and the lives of patients with R/R NPM1-m AML. Responsibilities Strategic Planning &amp; Brand Management Develop and execute annual tactical plans.&nbsp; Distill market research findings and sales trends into insights that direct promotional efforts. Coordinate with the market insights team to set future direction for insight generation. Manage promotional budget. Brand Management Monitor product performance and propose promotional adjustments based on market dynamics. Cultivate relationships with thought leaders, key customers, and professional organizations. Marketing Execution Develop promotional materials, campaign optimizations, and digital marketing initiatives in line with regulatory requirements. Execute multichannel marketing (digital, field force, print, CRM) for HCPs, patients, and value and access stakeholders Manage key vendor relationships, including the promotional agency of record and media planner Sales Enablement &amp; Cross-Functional Collaboration Closely collaborate with key functional partners (e.g., Sales, Sales Training, Regional Marketing, Alliance partners, Medical Affairs, Value &amp; Access, Advocacy, Legal/Compliance and Corporate Communications) to drive alignment on strategy, key messages, and tactical execution. Ensure key brand messages and materials are effectively communicated at sales meetings Collaborate with the sales team and sales training to create / optimize training materials and selling tools. Work closely with Medical Affairs to ensure scientific accuracy of marketing content. Coordinate with Regulatory Affairs for promotional approvals and compliance. Performance Management In collaboration with insights team, establish, integrate and track KPIs, performance metrics, and ROI for marketing activities. Compliance &amp; Governance Act as the marketing lead for MLR Ensure all marketing activities comply with local regulatory guidelines, industry codes (e.g., EFPIA, FDA, EMA), and company policies. Maintain high ethical standards in external interactions. The preceding job description has been designed to indicate the general nature and level of work performed by employees within this classification. It is not designed to contain or be interpreted as a comprehensive inventory of all duties, responsibilities and qualifications required of employees assigned to the job. JOB SPECIFICATIONS: High performing marketer with the ability to set a vision and provide direction across diverse internal and external stakeholders. Strategic thinker with innovative mindset and can make decisive decisions and recommendations among a set of key strategic choices. Must be confident working within a fast paced and entrepreneurial environment. Adept at forming and maintaining a collaborative work environment within cross functional teams. Excellent communication skills, highly competent presenter, able to gain credibility, engender trust and influence at all levels, strong partnering skills, bias for action and tangible results. Must have demonstrated excellence in project management and effectively directing and overseeing multiple projects/priorities. Leadership Qualities: Strategic Vision, Cross-functional Leadership, Project Management, Ability to influence with and without authority QUALIFICATIONS:&nbsp; Bachelor’s degree in relevant field, advanced degree preferred.&nbsp; Minimum of 7 years of experience in marketing at a biotech / pharmaceutical company in the oncology or hematology space.&nbsp; Proven track record of developing and implementing fully integrated marketing strategies for HCPs (personal and digital) and patients. Must have the ability to effectively collaborate with, motivate and influence various levels/grades within the organization and outside of the organization.&nbsp; Strong understanding of external stakeholder environment. &nbsp; Knowledge of marketing, strategic, planning, training, and market access&nbsp; Excellent communication and interpersonal skills, with the ability to collaborate effectively with internal and external stakeholders. &nbsp; Demonstrated ability to lead and inspire cross-functional teams.&nbsp; Passion for improving the lives of patients and caregivers affected by oncology and hematology conditions. Ability to travel up to 20% of the time; domestic and limited international&nbsp; Preferred Qualifications&nbsp; Sales experience is a plus Product launch experience preferred Strong analytical skills; comfortable navigating complex and ambiguous environments Experience with value and access integration Alliance partnership experience beneficial The base range for this role at the Director level is $224,000 - $260,000 and Senior Director level is $268,000 - $295,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp; #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director/Senior Director, US Marketing

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Kura Oncology is looking for a dynamic individual, who will have the ability to exercise good judgment in a variety of situations, with strong written and verbal communication, administrative, and organizational skills. The Senior Executive Assistant should have the ability to maintain a realistic balance among multiple priorities and will have the ability to work independently on projects, from conception to completion. The Senior Executive Assistant will provide specialized and advanced administrative support to the Chief Operating Officer (COO), Chief Legal Officer (CLO), VP Human Resources, and VP Clinical Operations. We are looking for a motivated self-starter and strong communicator with an elevated level of commitment, ownership, and sense of urgency. &nbsp; ESSENTIAL JOB FUNCTIONS: Primary support Chief Operating Officer, Chief Legal Officer and 2 VPs managing complex calendars based on key business priorities (ex. special projects, issues and escalations, time zone complexities). This involves networking with other executive assistant team members. Responsible for creating and coordinating all travel, including complex domestic and international travel with expected changes, and creating expense Responsible for assisting the Chief Legal Officer and finance department with board committee materials, SEC filings, D&amp;O questionaries, and equity document request Back up administrative support related to the Board of Directors materials and meetings. Develop meeting agendas, facilitate meetings (keeping agenda and goals on track), take minutes, and follow up on action items Organize all aspects for offsite conferences and external events, including catering and transportation Coordinate all contracts with contracting department and process POs to completion Employs tact and good judgment in confidential situations, and proven experience interacting with senior management, keeper of confidential information i.e. leadership team meeting topics, personal information related to employee performance, Proactively identifies and communicates issues, problems, and takes the opportunity to analyze and recommend conclusions. Reports appropriate feedback to their executive Anticipates upcoming needs as it relates to their scope of responsibility and executes appropriate course of action. Manage and correct deviations for timelines when applicable i.e. collection of documents, reports, and rollup of information, getting performance reviews in on time May manage, train and coaches less experienced administrative colleagues Collaborates with HR on interviewing efforts with senior leadership, as needed Assists with onboarding of new personnel into the department Handle Executives' personal agendas/commitments as Perform other duties as assigned. Budget management Active member on Events committees and supporting event initiatives as needed. Creation and ongoing maintenance of cloud-based file organization and records, upkeep of executives’ memberships, dues, etc. JOB SPECIFICATIONS: Bachelor’s degree preferred or a combination of experience and training. Familiarity with legal process, procedures, terminology, and documentation. 5 years of experience supporting C-level management within the biotech/ pharmaceutical industry preferred. Previous legal function support is a plus. Ability to work across time zones and exhibit flexibility in work schedule. Proficient with basic computer skills including typing and 10-key by touch, Word, Excel, PowerPoint, Outlook, Concur, WebEx/MS Teams SharePoint and Office 365 Project management experience strongly preferred. Biotech and/or start-up company experience strongly preferred. Ability to exercise discretion and independent judgment regarding highly sensitive and external communications. Excellent communication skills, verbal and written coupled with strong command of English High emotional intelligence and relationship-building skills at all levels of the organization. Ability to work collaboratively within administrative team. Maintains strong working relationship with other administrative support professionals in support of executive and company initiatives. Ability to exhibit professional communication/coordination with key external partners/stakeholders (i.e. members of the board, external counsel, etc..) Ability to work well with diverse Excellent professionalism and strong interpersonal skills. Must have a positive “can do” attitude and show excellent judgement as well as work well independently. Flexibility to accommodate rapidly changing priorities and deadlines. Must be flexible to work on-site at the Boston office location. Willingness to travel as needed for executive support. The base range for a Sr EA is $124,072 to $155,094 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Executive Assistant

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Essential Job Functions: This is a leadership position working with the Clinical Trial Management and Clinical Development functions to drive program execution of data science deliverables, operational excellence, implement scalable data processes, and provide scientific and technical leadership to ensure data integrity and regulatory compliance. The role is ideal for an experienced data sciences leader who thrives in a fast-paced, hands-on environment.&nbsp; Serve as the accountable data sciences leader for key programs, ensuring proactive risk management and issue resolution. Develop and execute the clinical data sciences strategy to support program pipeline and portfolio goals. Oversee end-to-end data management activities from study start-up through submission, including protocol development, database design, data cleaning, and lock. Ensure timely and accurate delivery of clinical data to support interim analyses, database locks, and regulatory submissions. Ensure study documentation and filing is maintained in an inspection ready state and provide leadership and direct support as required for audits and regulatory inspections. Oversee vendor partnerships (CROs, EDC providers, and other data service partners) and ensure adherence to timelines, budgets, and quality standards. Promote a culture of quality, innovation, and collaboration across operations and development functions. Drive process optimization and digital transformation initiatives. Provide direct study support as may be required to support business objectives. Lead and mentor a high-performing clinical data sciences team. Support establishment and maintenance of data standards in accordance with industry guidelines. Complete other duties assigned by manager. Job Specifications: B.A./B.S. or MA/MBA degree in Biology, Health Sciences, or related scientific field required. 10+ years in clinical data management/sciences within the pharmaceutical or biopharma industry. Prior leadership experience managing teams and overseeing multiple studies. Oncology experience. Extensive experience in managing external vendors (CROs, central laboratories, etc). Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects. Demonstrated expertise in EDC systems (Veeva EDC, Medidata Rave, etc.), data visualization platforms, and CDISC standards. Excellent communication skills. Analytical thinker with a data-driven mindset and attention to detail. Knowledge of health authorities’ rules and regulations governing clinical data collection, storage, transmission, and privacy. Flexibility to travel approximately 5-10% of time. The base range for an Associate Director is $176,800 - $208,000 and Director is $223,000 - $245,700 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

AD/Director, Clinical Data Sciences

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Working closely with senior executives and operational leaders of the company, assists in the execution of licensing opportunities, partnerships, mergers, acquisitions, and joint ventures. Initiate and lead discussions with the appropriate level of decision maker within potential biotechnology and pharmaceutical partners to establish ongoing and sustained dialogs around collaboration opportunities. Analyze the universe of prospective pharmaceutical customers and develop and execute on an approach leading to strategic partners as well as development partners to maximize the value of the Company’s programs, technology and intellectual property. Develop confidential and non-confidential program and technology packages and corporate overviews for prospective partners, including market potential, pre-clinical and clinical information Assesses potential business opportunities based on analysis of research data related to new products for the company. Partner with competitive intelligence team to enhance and maintain various relevant competitive landscape analyses, to inform deal negotiation strategy and overall BD strategy. Serves as a significant resource for licensing planning and implementation. Serves as a key organizational representative during the due diligence process in assessing targeted opportunities. Leads search &amp; evaluation efforts, recommends product acquisitions and/or the development of new products to meet the strategic goals of the company. Works closely with internal/external members of Legal, Development, Project Management, R&amp;D, and Finance in the development and implementation of strategies, plans and business models. Conducts financial modeling and commercial analysis to support strategic decision making. Formulates, negotiates and finalizes business agreements. Deliver business development updates covering account activity and work closely with management to ensure attainment of objectives. Complete other duties as assigned by supervisor. Job Specifications: Bachelor’s degree in life science discipline or equivalent. MBA preferred. Five + plus year’s relevant experience in business development with demonstrated success building business development initiatives in the biotech industry. Broad and detailed knowledge of all aspects of the pharmaceutical R&amp;D process from early discovery through to marketed products, in addition to expertise in business development. Knowledge of the market and competitive environment including deal activity and potential opportunities, particularly in the oncology space. Strong understanding of biopharma deal structures with extensive experience in negotiations, valuation, corporate finance, and deal structuring. Excellent communication and interpersonal skills, strong "active listening" skills, to effectively convey key recommendations to senior management, and proven ability to "think on your feet". Ability to work independently, in a fast-paced environment while demonstrating the ability to collaborate across and within teams. Demonstrated ability to establish new alliances and expand existing ones. Experience negotiating business development deals of significant financial value. Strong financial, analytical and program integration skills, familiarity with financial/deal modeling in Excel. Excellent written, verbal, and presentation communication skills, Must be familiar with Microsoft Office applications. The base range for this role is $196,000 - $226,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Manager/Associate Director, Business Development

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: We’re looking for a Vice President, Clinical Development (MD) to lead cross-functional clinical teams for the design and conduct of clinical studies. This position will report to the Chief Medical Officer. Lead cross-functional clinical teams for the design and conduct of oncology studies, specifically within the Darlifarnib franchise. Serve as the Clinical Development Lead on the Global Program Team, driving development strategy and driving integrated cross-functional decision-making across the lifecycle of the program. Ensure that scientific rigor and innovation drives Kura Oncology’s development strategies. Ensure excellence in both strategy and execution by partnering closely with colleagues in clinical operations, biostatistics, data management, program management and translational medicine. Serve as Medical Monitor of sponsored clinical research and as medical representative to CROs, reference laboratories and other organizations involved in the execution of clinical trials. Responsible for of all clinical regulatory deliverables and other clinical documents associated with the clinical trials under his/her direct responsibility, including protocols, and the clinical portion of INDs, CTAs, investigator brochures, CRF’s, annual IND reports, CSR’s and clinical expert reports, among others. Responsible for the analysis of clinical data, including safety monitoring in collaboration with PV. Participate in site initiation visits and other site visits at clinical center. JOB QUALIFICATIONS: Minimum of 10 years of relevant experience in drug development either in industry (preferred) or in academia. M.D. degree required. Proven track record of strong clinical research skills, including publications. Ability to partner with others to implement innovative development strategies. Experience in precision oncology/hematology preferred. Demonstrated excellence in independently leading and conducting research and ability to evaluate, interpret and present complex scientific data. Demonstrated written and excellent communication and interpersonal skills, with the ability to translate statistical concepts into layman's terms. Strong attention to detail with ability to understand the broader picture and priorities. Must be a dedicated self-starter with a high energy level and ability to achieve results. Must have strong communication and leadership skills-the ability to influence and work successfully with colleagues, customers, and corporate partners. The candidate should have experience in handling multiple projects at a time. Some travel may be required when appropriate. The base range for a Vice President is $397,000 - $450,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Vice President, Clinical Development

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Reporting to the Executive Director of R&amp;D Quality Assurance, the Associate Director, Clinical Quality Assurance (CQA) is responsible for supporting the development and implementation of processes and programs that provide quality and compliance oversight utilizing proactive end to end strategies for all clinical development programs, and pharmacovigilance activities. The incumbent is also responsible for supporting relevant processes and programs ensuring appropriate computer system validation/assurance (CSV/A) activities are completed for applicable clinical systems. The incumbent builds collaborative, supportive relationships and serves as a point of contact for Quality Assurance across clinical development programs and relevant departments including clinical development, trial operations, pharmacovigilance, clinical data sciences, and other relevant stakeholders. Supports and maintains a quality-focused culture and mindset across the organization. ESSENTIAL JOB FUNCTIONS: Develop collaborative partnerships with clinical study teams/study team leaders to maintain a current understanding of potential areas of quality risk exposure within the context of ongoing clinical studies and across clinical programs as assigned. Ensure compliance with clinical quality assurance activities including facilitating and managing internal and external GCP audits/audit programs, as applicable. Implement and support QA activities that foster an outcome of compliance and adherence to relevant laws, regulations, guidance; upholds the rights and welfare of patients; is focused on data integrity and end to end quality assurance Assist in identifying opportunities for process improvement initiatives, including process/program reviews to identify approaches that will prevent quality issue recurrence (e.g. issue escalation and management; and applicable corrective/preventative action programs, periodic internal audit/gap assessment). Assist with the development and tracking of trending and metrics of internal as well as external vendor quality issues. Provide related training on new regulatory requirements and industry practices. Lead and manage clinical inspection readiness activities for assigned programs and other key programs as applicable. Support Regulatory Inspections of Kura Oncology products, including supporting/facilitating back room and front room activities and supporting the drafting/reviewing of responses to regulatory authority findings, as applicable. Promote quality and risk management principles (e.g., quality by design, critical to quality focuses, risk assessment and risk ranking, establishment of risk thresholds and tolerance limits) when supporting innovative programs and advancing ongoing clinical programs. Maintain accountability for ensuring risk-based strategies are utilized when managing and mitigating quality issues and supporting clinical studies, ensuring study-specific risk management activities and strategies are utilized consistently across programs. JOB SPECIFICATIONS: BA/BS degree required, advanced degree a plus A minimum of 8 years of experience in the bio-pharmaceutical R&amp;D industry with at least 6 or more years in a current, hands-on GCP Quality Assurance Demonstrated experience drafting, reviewing, implementing, and optimizing standard operating procedures (SOPs). Demonstrated knowledge and application of Global regulations and guidance for GCP, GVP, and CSV/A Direct experience in the conduct and reporting of internal and external audits, root cause analysis and the translation of findings into corrective actions plans that mitigate risks to study subjects, data integrity and clinical programs. Experience preparing for, participating in, and subsequent response to health authority GCP/GVP inspections/partner audits. Working knowledge of Veeva (or similar QMS e-system) required. Knowledge of Inspection Management Tools a plus. Ability to write clear quality position statements, risk-based audit reports, and procedures. Excellent oral and written communication Strong judgment, project management and decision-making skills; able to manage multiple projects and demanding timelines. Operational Experience (e.g., Clinical Operations, Data Management), work in both clinical and commercial stage organizations; and/or experience as a trainer are an advantage. The base range for an Associate Director is $170,000 - $190,000 per&nbsp;year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Director, Clinical Quality Assurance

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Reporting to the Senior Director of IT and Facilities, the IT Security Analyst serves as the primary operational lead for cybersecurity, vendor risk, and data privacy programs at Kura. This role is responsible for strengthening the company’s security posture, supporting regulatory and audit requirements, and ensuring continuous improvement of detection, response, and risk management capabilities in a highly regulated life sciences environment. The IT Security Analyst partners closely with internal stakeholders and external security service providers to identify, assess, and mitigate risk. This position acts as a subject matter expert for information security, third party risk, and audit readiness, and plays a critical role in promoting a security first culture across the organization. The ideal candidate will bring deep experience in regulated life sciences environments, demonstrates strong leadership and cross functional collaboration skills, and thrives in fast paced, high growth organizations. Enhance and mature Kura’s cybersecurity program, strengthening systems, processes, and controls to meet evolving regulatory and data privacy requirements. Own and administer the third party risk management and data privacy platform, including configuration, assessments, remediation tracking, reporting, and continuous improvement in partnership with Legal, Compliance, Procurement, and Quality. Coordinate vendor security assessments and track remediation activities to reduce third party risk exposure. Serve as the operational owner for the managed security services provider and related security monitoring platforms, ensuring effective alert triage, incident response coordination, use case tuning, and reporting. Lead and support security incident response activities, including investigation, containment, remediation, and documentation. Oversee vulnerability management activities, including vulnerability scanning, reporting, and remediation coordination across endpoints, infrastructure, and applications. Partner with internal teams and external providers to conduct security assessments, penetration testing, disaster recovery exercises, and tabletop simulations. Oversee and continuously improve the cybersecurity awareness and training program to strengthen the organization’s security culture. Research, evaluate, recommend, and implement appropriate security tools and technologies aligned with organizational risk priorities and direction from the Director of IT. Support patch management oversight by validating that security updates are applied in accordance with defined standards and timelines. Monitor configuration standards and security controls to maintain appropriate risk levels across endpoints, identity platforms, and infrastructure. Serve as the primary operational owner for IT security audit readiness, including evidence collection, documentation, and control validation in support of internal and external audits. Provide risk based recommendations to IT leadership regarding security strategy, roadmap initiatives, and remediation priorities. Stay current on emerging cybersecurity threats, regulatory expectations, and industry best practices relevant to life sciences and regulated environments. Champion information security, privacy, and risk awareness across the organization. JOB QUALIFICATIONS: 7 plus years of progressive experience in information security, cybersecurity operations, or risk management. 3 plus years of experience supporting security programs in a regulated environment such as pharmaceutical, biotechnology, medical device, or similar industries preferred. Demonstrated experience operating third party risk management and data privacy platforms, including vendor assessments and remediation tracking. Hands on experience with security monitoring and detection technologies such as SIEM, EDR, MDR, MSSP, vulnerability management tools, and endpoint security platforms. Strong understanding of cybersecurity frameworks and regulatory standards including NIST CSF, ISO 27001, SOC 2, SOX IT controls, and 21 CFR Part 11. Experience supporting internal and external audits and regulatory inspections. Ability to assess technical risk and translate regulatory requirements into practical security controls and processes. Strong analytical and investigative skills with the ability to prioritize risks and recommend business aligned solutions. Excellent written and verbal communication skills, including the ability to communicate risk concepts to technical and non-technical stakeholders. High level of discretion, integrity, and ability to handle confidential and sensitive information. Bachelor’s degree in Information Technology, Computer Science, Information Security, or related field, or equivalent practical experience. Relevant certifications such as CISSP, CISM, CRISC, Security+, or similar are preferred. The base range for this role is $156,586 - $185,630&nbsp;per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Manager, IT Security Analyst

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: We are seeking a visionary executive to spearhead the formation and growth of a high-impact startup company focused on the discovery and development of menin inhibitors for diabetes and cardiometabolic indications. This is a high-growth leadership opportunity for an experienced leader ready to build a lean, science-driven organization from the ground up and accelerate the development of Caspian’s lead program, which is initially focused on generating clinical, proof-of-concept data in Type 1 diabetes. In addition to serving as a senior executive leader, the successful candidate will oversee early clinical development of the company’s lead program, currently in IND-enabling studies, providing scientific, operational, and organizational leadership to ensure the seamless transition from research into early clinical development. This role represents a unique opportunity to combine entrepreneurial leadership with scientific and clinical development stewardship. The successful candidate will play a central role in shaping both the company and its clinical pipeline; ultimately helping to deliver transformative therapies to patients with diabetes and cardiometabolic disease. Strategic Leadership and Corporate Growth Serve as the principal executive leader responsible for establishing and growing Caspian into a high-performing biotechnology company. Work in close partnership with the CEO and leadership team at Kura Oncology to accelerate the transition of Caspian Therapeutics from an early-stage research organization to a clinically focused development company. Lead creation, translation, and execution of strategic business plans, from conceptualization through early commercialization planning. Be instrumental in developing both short- and long-term corporate strategy, including operational planning, resource allocation, and financial management. Establish and maintain key external relationships with the Caspian Therapeutic board of directors, investors, partners, advisors, investigators, CROs, and other stakeholders while maintaining awareness of the competitive and regulatory landscape. Early Clinical Development Leadership Serve as the strategic leader for Early Clinical Development, providing guidance and oversight of integrated development plans as assets transition from discovery into clinical evaluation. Lead the design and execution of translational and early clinical strategies to enable efficient first-in-human and proof-of-concept studies. Ensure seamless transition of drug candidates from research to early clinical development through close collaboration with research, regulatory, CMC, and clinical operations functions. Define clinical development pathways, target product profiles, and early development milestones aligned with corporate objectives. Operational Accountability As the organizational leader, be accountable for ensuring that activities within Early Clinical Development are executed within expected scope, budget, and timelines. Establish key milestones for development programs and provide direct leadership and organizational influence to ensure milestones are achieved or exceeded. Oversee clinical program planning, study design, vendor selection, and operational execution in partnership with internal and external teams. Closely monitor program performance and collaborate with strategic partners such as Kinexum to ensure efficient program delivery. Manage budgets and resources to support rapid, cost-effective advancement of the KO-7246 program and future pipeline assets. Hands-On Organizational Leadership Take on a broad range of duties across the organization, helping to build core capabilities and infrastructure as the company scales. Drive cross-functional alignment between research, clinical, regulatory, and commercial planning teams. Provide mentorship and leadership to build a high-performing, science-driven organization. JOB QUALIFICATIONS: Advanced scientific background: PhD or MD strongly preferred. Significant experience in early clinical development with a strong track record of advancing programs from discovery into the clinic. Requires the ability to influence and lead at the executive level. Proven ability to build, scale, and lead organizations in a biotechnology environment. Demonstrated experience overseeing development plans, budgets, timelines, and cross-functional execution. Strong ability to prioritize multiple demands and projects. Has a broad background with an emphasis in clinical development, project leadership and deep understanding of clinical operations. Spearhead strategic business planning and execution, driving measurable growth. Possesses a hands-on approach and a willingness to engage in all aspects of project execution. The base range for a Vice President is $325,000 - $380,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Head of Early Development, Caspian Therapeutics

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Working closely with senior executives and operational leaders of the company, assists in the execution of licensing opportunities, partnerships, mergers, acquisitions, and joint ventures. Initiate and lead discussions with the appropriate level of decision maker within potential biotechnology and pharmaceutical partners to establish ongoing and sustained dialogs around collaboration opportunities. Analyze the universe of prospective pharmaceutical customers and develop and execute on an approach leading to strategic partners as well as development partners to maximize the value of the Company’s programs, technology and intellectual property. Develop confidential and non-confidential program and technology packages and corporate overviews for prospective partners, including market potential, pre-clinical and clinical information Assesses potential business opportunities based on analysis of research data related to new products for the company. Partner with competitive intelligence team to enhance and maintain various relevant competitive landscape analyses, to inform deal negotiation strategy and overall BD strategy. Serves as a significant resource for licensing planning and implementation. Serves as a key organizational representative during the due diligence process in assessing targeted opportunities. Leads search &amp; evaluation efforts, recommends product acquisitions and/or the development of new products to meet the strategic goals of the company. Works closely with internal/external members of Legal, Development, Project Management, R&amp;D, and Finance in the development and implementation of strategies, plans and business models. Conducts financial modeling and commercial analysis to support strategic decision making. Formulates, negotiates and finalizes business agreements. Deliver business development updates covering account activity and work closely with management to ensure attainment of objectives. Complete other duties as assigned by supervisor. Job Specifications: Bachelor’s degree in life science discipline or equivalent. MBA preferred. Seven + plus year’s relevant experience in business development with demonstrated success building business development initiatives in the biotech industry. Broad and detailed knowledge of all aspects of the pharmaceutical R&amp;D process from early discovery through to marketed products, in addition to expertise in business development. Knowledge of the market and competitive environment including deal activity and potential opportunities, particularly in the oncology space. Strong understanding of biopharma deal structures with extensive experience in negotiations, valuation, corporate finance, and deal structuring. Excellent communication and interpersonal skills, strong "active listening" skills, to effectively convey key recommendations to senior management, and proven ability to "think on your feet". Ability to work independently, in a fast-paced environment while demonstrating the ability to collaborate across and within teams. Demonstrated ability to establish new alliances and expand existing ones. Experience negotiating business development deals of significant financial value. Strong financial, analytical and program integration skills, familiarity with financial/deal modeling in Excel. Excellent written, verbal, and presentation communication skills, Must be familiar with Microsoft Office applications. The base range for this role at an Associate Director level is $180,000 - $208,000 and Director level would be $228,000 - $265,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Director/Director, Business Development

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Join us as we embark on an exciting journey in transforming the treatment landscape of acute myeloid leukemia (AML). We are seeking a dynamic and experienced Associate Director / Director, Marketing Promotions to play a critical role in the development, approval, and execution of core promotional materials supporting KOMZIFTI (ziftomenib) in relapsed / refractory (R/R) NPM1-m AML. Reporting to the Senior Director of Brand Strategy and Marketing, this role will lead the end-to-end execution of promotional tactics, including MLR submission and approval, sales force rollout, and digital marketing execution, while supporting broader brand strategy. The successful candidate will bring strong experience partnering with field teams, managing agencies, and working cross-functionally in a highly regulated oncology environment. Responsibilities Strategic Planning &amp; Brand Management Lead development and execution of annual tactical plans in alignment with brand strategy.&nbsp; Distill market research findings and sales trends into insights that direct promotional efforts. Promotional Development &amp; Execution Lead the development of core promotional materials, including print, digital, and field-facing assets, from concept through MLR review, approval, and final production for HCP and patient audiences. Own and manage the MLR process, ensuring compliant, high-quality materials are delivered on time. Drive effective rollout of approved promotional tactics to sales teams, in close collaboration with Sales, Sales Training, and Commercial Operations Ensure promotional materials effectively translate brand strategy into clear, actionable field tools. Digital &amp; Omnichannel Execution Lead execution of digital marketing tactics, including email, web, virtual engagement tools, and non-personal promotion. Manage media agency to optimize channel mix, implement tactics, measure performance, and optimize future tactics accordingly across HCP and patient audiences. Ensure digital tactics align with brand strategy and compliance requirements Sales Force &amp; Field Engagement Serve as a key marketing partner to the field organization, incorporating field insights into promotional development. Demonstrate proven experience translating brand strategy to field teams at sales meetings and field training initiatives. Act as a trusted point of contact for sales leadership, ensuring alignment between marketing execution and field needs. Performance &amp; Budget Management In collaboration with insights team, establish, integrate and track KPIs, performance metrics, and ROI for marketing activities. Monitor product performance and propose promotional adjustments based on market dynamics. Prepare and deliver clear, concise presentations to senior leadership, including updates on promotional plans, execution status, and performance insight Manage promotional budget. Job Specifications: Bachelor’s degree in relevant field, advanced degree preferred. Minimum of 7 years of experience in biotech or pharmaceutical marketing, preferably in oncology or hematology Demonstrated experience leading&nbsp;promotional material development and MLR review Proven track record of&nbsp;working directly with sales and field teams Strong experience managing&nbsp;external agencies (creative, digital, production) Experience executing&nbsp;digital and omnichannel marketing tactics in a regulated environment Ability to work effectively in a highly&nbsp;cross-functional organization Strong communication and interpersonal skills, with comfort&nbsp;presenting to senior leadership Highly organized, detail-oriented, and able to manage multiple priorities Ability to travel up to 20% (domestic with limited international) Sales experience is a plus Product launch experience preferred Strong analytical skills; comfortable navigating complex and ambiguous environments Alliance partnership experience beneficial &nbsp; The base range for this role at an Associate Director level is $180,000 - $215,000 and Director level would be $223,000 - $258,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Associate Director/Director, US Marketing Promotions

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Leads the planning and execution of a complex, global clinical trial from start-up through close-out, in compliance with regulations/SOPs, within budget and timelines. Provides oversight and guidance to clinical operations personnel assigned to the clinical trial. Partners closely with Clinical Development, Regulatory Affairs, Data Management, Biostatistics, Safety, and other functions to ensure aligned and efficient trial execution. Establishes strong relationships with investigators and KOLs. Contributes to the development and review of key study documents including protocols, ICFs, monitoring plans, EDC specifications and statistical analysis plans. Contributes to the selection of vendors and CROs. Manages and oversees CROs, vendors, and other external partners to ensure high-quality performance and adherence to expectations. Develops, manages, and tracks clinical trial budgets, ensuring studies are delivered within approved financial parameters. Provides regular, clear updates on study status, risks, and milestones to senior leadership and key stakeholders. Proactively identifies operational risks and implements mitigation strategies to maintain timelines, quality, and compliance. Supports and facilitates execution of contracts, clinical trial agreements, and study budgets. Direct manager of approximately 1-2 direct reports. Provides expert input into the building of department infrastructure, including developing, training, and retaining the clinical operations team; ensures prioritization of activities and resourcing is in line with clinical development programs. Drives the creation of clinical operations Standard Operating Procedures (SOPs), systems, and processes across the trials; ensures compliance with regulatory and other applicable standards and guidelines. Fosters a highly collaborative culture and serves as a leadership role model within the company and with external stakeholders. Complete other duties as assigned by the manager. JOB SPECIFICATIONS: Bachelor’s degree in science/healthcare field, a nursing degree, or equivalent combined education. 10+ years of strong hands-on experience leading large, complex Phase 3 clinical trials preferably in oncology/hematology in US, Asia, Europe; or equivalent combination of training and experience. Proven ability to build strong relationships with external partners, CROs, and vendors including extensive experience managing contracts and clinical finance activities. In-depth, working knowledge of Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. Ability to work independently and collaboratively in a fast-paced, matrixed, team environment consisting of internal and external team members. Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines. Excellent verbal and written communication skills. Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects. Flexibility to travel domestically and internationally as required. Experience with Investigational New Drug applications (INDs) and New Drug Applications (NDAs) submissions. Experience setting up clinical trials outside of US and Europe is a plus. Field monitoring and/or clinical data management experience preferred. Proficiency with Microsoft Project The base range for a Director is $228,000 - $252,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Director, Clinical Trial Management

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Day-to-day operation and maintenance of laboratory and office facilities. Organize and help maintain the lab, manage the lab consumable inventory, take care of stocking supplies, schedule refrigerator/freezer cleanings, pipette calibrations, maintain organization of the lab inventory. Order, stock, and track inventory which includes reagents, consumables, first aid items, and other lab and office supplies. Arranging FedEx Shipments and receiving deliveries. Manage service providers and vendor contracts related to the maintenance, calibration, and repair of facility and utility equipment and building systems. Maintain the labs facility and utility practices, policies, and procedures Coordinate the instrument preventive maintenance schedule. Ensures adherence to lab standards and practices to maximize safety and operational effectiveness Responsible for lab shipments to/from company while maintaining safe shipping and handling standards. Manage all chemical and biological waste streams, including proper storage, labeling and disposal. Maintain required Chemical Inventory. Manage system for Safety Data Sheet (SDS) record keeping. Track warranty expirations and contact vendors for renewal. Drive continuous improvement in all aspects of the laboratory operations Provide excellent customer service when interacting with lab users, third party vendors, and other departments Proactive communication with end users on scheduled maintenance, status updates, and issues that may impact lab use Assist with arranging maintenance and service on equipment Escort service vendors for equipment maintenance and repairs Serve as EH&amp;S point of contact and safety monitor Support and lead city/state inspections and audits Monitor systems, liquid nitrogen, and dry ice levels; place orders as needed Act as first responder for temperature alarm systems Manage and act of PoC for HVAC in office and lab spaces. Respond to urgent lab issues such as equipment failures, sample transfers, leaks or facility related issues General facilities duties such as lunch orders, stocking kitchen, and running dishwasher Provide back-up reception support as needed. Assist facilities team with event setup. Other tasks as may be assigned as needed JOB SPECIFICATIONS: Prefer a Bachelor’s degree or a combination of equivalent education, training or experience. 2+ years of job experience working supporting lab operations in a biotech or pharmaceutical setting Ability to speak effectively and communicate to visitors in a professional manner.&nbsp; Ability to work in a flexible, fast-changing environment and respond to needs quickly. Must be a team player who excels at customer service.&nbsp; Will be detail oriented with strong attention to detail and have demonstrated experience prioritizing and organizing multiple tasks simultaneously. Punctuality and a positive, cheerful attitude is a must. Must be able to stand on your feet for long periods of time and lift 25+lbs The base range for this role is $21 - $30 per hour. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Facilities & Lab Coordinator

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Reporting to the Regional Business Director, the Oncology Account Manager (OAM) will contribute to Kura’s overall sales objective by performing assigned Sales and Account Management related activities in the NYC territory (inclusive of the 5 boroughs). The OAM will provide physicians, pharmacists, nurses and all healthcare professionals (HCPs) with product, services and approved information that will enable the HCPs to appropriately prescribe Kura’s product(s)The OAM will compliantly and successfully implement Kura’s marketing strategies and corresponding tactics in order to achieve short-term and long-term objectives. The ideal candidate will be capable of managing the territory and administrative requirements in an efficient and effective manner and will achieve full compliance with drug laws and regulations when representing Kura and Kura’s products to Healthcare Providers.&nbsp; ESSENTIAL JOB FUNCTIONS: Achieve the assigned sales objective for the territory Attain the designated goals for calls on appropriate healthcare professionals to communicate balanced, accurate, and complete information on Kura’s FDA approved products Develops and implements a territory business plan to meet customer needs and achieve goals Navigate through complex external/customer organizational structures including hospitals, IDNs, GPOs and healthcare communities while aligning with cross-functional commercial partners Demonstrate completion of administrative requirements including budget management, expense reports management, CRM call reporting and synchronization, etc. within timelines and company guidelines Demonstrates a deep understanding of healthcare professionals (HCP) and account needs, effectively utilizing this knowledge to strategically promote and expand the use of assigned products Operate the territory within the assigned expense budget and demonstrates fiscal responsibility Comply with all federal/state/local laws, regulations and guidelines including but not limited to the PhRMA Code on Interactions with Healthcare Professionals as well as complying with all Kura standards and policies relating to all job activities Successful completion and ongoing updates of all aspects of training including but not limited to product knowledge, disease state, market, selling skills and compliance Assists in the identification and resolution of issues and opportunities while communicating proactively to marketing and sales management Develops and consistently demonstrates an expert understanding of HCP and Account needs to appropriately expand use of assigned product.&nbsp; JOB SPECIFICATIONS: Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration 6+ years of successful pharmaceutical/biotech sales experience with 3+ in the oncology/hematology and/or rare disease markets, preferably with oral therapeutic selling experience Management of large territories that includes periodic overnight travel Occasionally work evenings and weekends as needed for conferences Excellent written and oral communication skills Strong computer skills, notably WORD, EXCEL and POWER POINT The base range for this role is $210,000 to $230,000 per year with a target IC of 60k. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Oncology Account Manager - NYC

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Senior Director of Pharmacovigilance (PV), Safety Sciences &amp; Surveillance, provides strategic and operational leadership for global safety surveillance activities across Kura’s clinical and post-marketing programs. This individual is responsible for signal detection and evaluation, benefit-risk assessment, and safety surveillance strategies, for the company’s products. This role ensures compliance with global pharmacovigilance regulations and drives proactive risk management to protect patients and support product development. This position partners cross-functionally with Clinical Development, Nonclinical, Regulatory Affairs, Biostatistics, and Quality to ensure robust safety oversight throughout the product lifecycle Strategic Leadership Lead the Safety Sciences/Surveillance function, setting strategies for signal detection, risk management, and aggregate safety reporting. Lead safety strategy contributions to regulatory submissions, and lifecycle management strategies. Serve as safety lead on cross-functional governance committees (e.g., Safety Monitoring Committees). Safety Surveillance &amp; Signal Management Drive the development and continuous evolution of safety signal detection methodologies and product-specific signaling strategies.&nbsp; Lead signal validation, prioritization, and assessment processes in alignment with global regulations; interpretation of safety signals and trends; communication of safety assessments (written and verbal) of safety risks in collaboration with other functional stakeholders. Risk Management &amp; Regulatory Strategy Provide strategic oversight for Risk Management Plans (RMPs), REMS (if applicable), and other risk minimization activities. Serve as safety representative in interactions with global regulatory authorities. Ensure inspection readiness and support health authority audits/inspections. Aggregate Reporting &amp; Safety Communications Oversee preparation and review of aggregate safety reports (DSURs, PSURs/PBRERs, aggregate reports for anticipated events). Ensure alignment of safety messaging across clinical, regulatory, and medical communications. Provide strategic direction of safety content for key regulatory documents (e.g., DSURs, PSURs, IBs, protocols, RMPs) ensuring consistency and scientific rigor. Cross-Functional Collaboration Partner with Clinical Development on safety monitoring strategies and DMC interactions. Collaborate with Biostatistics on integrated safety analyses. Provide safety expertise to Medical Affairs and Commercial teams for post-marketing surveillance, as needed. Compliance &amp; Quality Maintain oversight of safety vendors and CROs supporting surveillance activities. Contribute to SOP development and continuous improvement of PV systems and processes. Support inspection readiness activities, internal audits and external inspections. Team Leadership Mentor and develop a high-performing Safety Sciences team. Foster a culture of scientific rigor, accountability, and patient focus. Manage departmental budget and resource planning. JOB SPECIFICATIONS: PharmD or PhD in life sciences preferred. Advanced clinical or regulatory training highly desirable. 12+ years of experience in pharmacovigilance or drug safety. 5+ years in leadership roles within Safety Sciences, Signal Detection, or Safety Surveillance. Experience supporting global regulatory submissions and health authority interactions preferred. Strong background in oncology required. Experience in both clinical development and post-marketing safety preferred. Strong knowledge of signal detection methodologies and benefit-risk assessment. Experience in the principles and techniques of data analysis, proficient in the use of data analysis/visualization software. Working knowledge of industry standard safety databases, Regulatory databases, and other electronic data capture systems; working knowledge of MedDRA and WHODrug dictionaries. Proven experience authoring and reviewing aggregate safety reports. Demonstrate a deep understanding of and ensure compliance with current global PV regulations (FDA, EMA, CIOMS, ICH E2 guidelines). Strategic thinker, a self-starter with strong scientific judgment. Executive presence and ability to influence cross-functional stakeholders. Excellent written and verbal communication skills. The base range for a Senior Director is $274,000 - $330,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Director, Pharmacovigilance (Safety Science & Surveillance)

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Senior Director, Medical &amp; Regulatory Writing serves as subject matter expert on clinical protocols, protocol amendments, clinical study reports, Investigator’s Brochures, and briefing books. May also provide guidance on document strategy for more complex dossiers for regulatory submission such as IND and NDA/BLA filings. The position requires the ability to work collaboratively with cross-functional teams in a fast-paced environment. The qualified candidate will also have experience in management of external vendors and the development of operational process improvements such as work practice documents, SOP development and updates, and document templates. There will need to be a very strong understanding of document timelines as planning is critical. Provides leadership, strategy, and oversight of the Medical &amp; Regulatory Writing team. Serves as subject matter expert in preparing clinical regulatory documents through all phases clinical research. Represent medical writing in cross-functional team meetings. Collaborate with department heads and staff members of cross-functional groups, including clinical research, clinical operations, data management, biostatistics, regulatory affairs, and medical affairs as necessary to deliver documents with high quality on time. Adhere to established regulatory standards, including ICH-E3 guidelines and company SOPs. Support the development, improvement and maintenance of medical writing work practice documents, SOPs, and document templates to ensure consistency and efficiency. Oversight of vendors including contract writers, QC reviewers, and document formatters. Must have proficiency in the use of EndNote or RightFind Cite It software for the citation of literature references and creation of list of references in Word documents. Maintain current knowledge of industry trends and best practices for medical writing Performs other duties as assigned JOB SPECIFICATIONS: Bachelor’s, Master’s or PhD Degree in scientific, medical, clinical discipline or related field is required. Masters or Ph.D. degree is preferred. Strong track record of people management and delegating work. 12+ years of relevant industry experience as a medical writer in a pharmaceutical, biotech, or CRO environment. Oncology experience preferred. Must have experience authoring clinical study reports, protocols, protocol amendments, Investigator’s Brochure. Experience authoring and managing briefing books is a plus. Experience in regulatory submissions (clinical study reports) presented to regulatory authorities a plus Strong understanding of federal regulations, Good Clinical Practices, and ICH guidelines a plus Project management skills as related to medical writing. Ability to manage complex writing projects with minimal supervision. Must have the ability to edit text for brevity and clarity. Ability to understand, interpret and present complex clinical data. Must be highly detail oriented. Ability to coordinate multiple documents while effectively managing timelines. High degree of independence in decision making and problem solving. Leads decision-making across multiple programs or areas, setting direction and making strategic trade-offs that impact cross-functional execution and outcomes. Drives cross-functional alignment across multiple programs, influencing stakeholders to shape strategy and ensure cohesive execution across functions. Understanding of FDA and ICH regulations and guidelines. Familiarity with eCTD-compliant templates and with the use of document formatting tools such as ISI writer, Liquent Smart Desk, Acumen Stylus, or other formatting tools. Must be an expert with MS Word and have a solid working knowledge of MS Excel, MS PowerPoint, and MS Project. Experience in use of an EDMS such as Documentum, Core Dossier, or Veeva. The base range for this role at the Senior Director level is $265,000 - $306,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp; #LI-RM1 &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of&nbsp;November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice CA Privacy Notice

Senior Director, Medical & Regulatory Writing

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Manage Senior Accountant and ensure timely, accurate processing of journal entries, reconciliations and various account analyses for R&amp;D functions such as translational research, development, diagnostics, pharmacology, and regulatory affairs, and adherence to company policies. Review and approve invoices for payment. Ensure proper coding, two-way match, and approval workflows. Perform and review journal entries and balance sheet reconciliations for key accounts such as accrued R&amp;D contracts, prepaid R&amp;D ST, and prepaid R&amp;D LT. Review various related parties and partner transactions including reconciliations, and analysis. Perform and review monthly and quarterly variance analyses for operating expenses, R&amp;D functions, projects, and key accounts; investigate and resolve discrepancies proactively. Ensure compliance with U.S. GAAP, SOX requirements, and internal accounting policies across all responsible functions and processes. Support the design, implementation, and ongoing maintenance of Sarbanes‑Oxley internal controls, including documentation and testing. Assist with external financial audits by preparing schedules and responding to auditor requests and inquiries. Review monthly purchase order coding, partner with project managers and accounting staff to ensure proper coding for all new purchase orders. Apply strong analytical skills and critical thinking to identify issues, recommend improvements, and enhance the accuracy, efficiency, and quality of accounting processes. Perform additional duties and ad hoc projects as needed to support Finance leadership and departmental goals Job Specifications: Bachelor’s degree in accounting, or other related discipline, or the equivalent knowledge and experience required. Experience in the biotech/pharmaceutical industry required A minimum of 6-8 years’ relevant accounting experience, preferably in a combination of the following monthly close process, bank reconciliations, balance sheet reconciliations, contract accruals Excellent communication and people skills and the ability to interface with various levels of co-workers, upper management, and external customers while maintaining a high degree of confidentiality. Experience working in publicly traded company and life science industry preferred. Knowledge of US GAAP and internal control principles for a public corporation. ERP experience required; experience with NetSuite, Blackline, Coupa and Concur preferred. Skilled in the use of Microsoft Office Suite with intermediate to advanced Excel skills. Detail oriented with good analytical skills. Exercises independent judgment in managing operational decisions within their area; proactively identifies issues and determines when to escalate more complex or cross-functional decisions. Serves as a key point of contact for cross-functional partners withing their area, ensuring alignment and proactively addressing coordination needs to support team deliverables. Strong time management skills and ability to independently organize multiple tasks of varying priorities and meet critical deadlines in a fast-paced environment. Ability to work in team environment and willing to assist other team members to achieve team goals and objectives. The base range for this role at a Senior Manager level is $143,000 - $176,500. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives. Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at&nbsp;www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice&nbsp;CA Privacy Notice

Senior Manager, Accounting

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.The Regional Sales Director will lead a field sales team from training, launch excellence and sustainable sales achievements. They will work with the field sales team and in partnership with all cross functional partners to support commercial excellence and positive experiences with all customer segments. The Regional Sales Director will ethically and compliantly deliver sales goals at or above targeted plans for all given measurement periods for their geographical areas of responsibility.Essential Job Functions Identify, recruit, hire, train, develop, motivate and retain top performing field sales personnel Prepare field-level action plans and lead and manage the behaviors needed to support the successful execution of the plans Field expert in market, competition, disease state, customer segments and commercial opportunity landscapes Understand and interpret sales and data reports and apply proactively and reactively clear and specific direction to drive specific behaviors and sales performance Establish and build key customer relationships to provide appropriate clinical and business support to drive area performance Effectively, efficiently and appropriately triage internal and external customer needs, issues and request in order to lower or remove barriers to core success factors Coach, teach and lead teams to engage customers in order to establish the foundation of disease awareness, appropriate patient profiles and compliant product utilization Execute recurring field visits with field team and provide timely written and verbal feedback Work with and partner with marketing, training, access and operations to deliver strategic imperatives while providing real-time feedback and suggestions on areas to continually improve organizational and operational excellence Constantly evaluate all internal and external factors in order to provide suggestions and guidance on more effective ways to meet and exceed goals Be the field facing lead for establishing the Kura Oncology name within the oncology-hematology community Fiscal responsibility and budget management to achieve maximize sales results Maintains highest level of compliance and ethics for self, team and organization Job Requirements Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration 10+ years of pharmaceutical/biotech commercial experience within the oncology/hematology and/or rare disease markets, with a minimum of 5 years of experience managing direct reports and leading teams in oncology and/or rare disease Successful and documented track record of attracting, developing and retaining talent and building high performing teams Experience in pharmaceutical/biotech marketing, managed care/market access, commercial operations and/or sales training a plus Launch preparation and successful launch experience in oncology/hematology; rare disease experience a plus Strategic and analytical thinking as demonstrated by key projects/initiatives Strong cross-functional leadership skills and ability to collaborate effectively within various groups Managerial Courage Excellent written and oral communication skills Strong computer skills, notably WORD, EXCEL and POWER POINT The base range for the RSD is $268,000 - $312,000 per year with a target bonus of $90,000. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives. Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at&nbsp;www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice&nbsp;CA Privacy Notice

Regional Sales Director, Central Territory

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: The Manager, Biosample Operations plans, implements, manages and drives biological sample logistics within Kura Oncology Phase I-IV Clinical Trials, working within our Clinical Operations function, under the leadership of the Head of Clinical Operations (or designee) and in collaboration with Clinical Trial Leaders (CTLs) and cross-functional development team. The Manager, Biosample Operations advises on and delivers the biosample strategy within clinical program(s) in accordance with the requirements of quality, and ethical and regulatory standards, including ICH/GCP/GLP. Ensures standardization and harmonization of biosample activities across clinical trials and oversight of sample collection, processing, storage, and reconciliation, maximizing biosample sample accrual and quality. Review clinical study protocols, informed consents, laboratory documents, case report forms, and service provider laboratory scope of work documents for sample handling details. Responsible for ensuring ethical use of biosamples collected in Kura Oncology clinical trials. Accountable for planning, coordinating, and overseeing all operational activities required to manage the lifecycle of patient samples (oversight of sample collection at site, shipment to vendor for testing/processing, analysis and final sample disposition) Ensures project level consistency occurs for biosampling across studies and is the primary point of contact for project, clinical, and study teams; contributing to innovation and improvement activities in collection, processing and data delivery. Track and report on biosample management status/progress, address issues, and resolutions. Collaborate with internal and external team members Complete other duties as assigned by the manager. JOB SPECIFICATIONS: Bachelor’s degree in science/healthcare field, a nursing degree, or equivalent combined education. A minimum of 4-6 years of clinical trial management experience preferred. 2+ years of strong hands-on experience in clinical biosample project management preferred. Must understand the drug development process in order to effectively manage internal and external cross-functional teams. Proven ability to build strong relationships with external partners, CROs, and biosample vendors In-depth, working knowledge of Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. Knowledge of regulations and requirements for clinical trial authorization and tissue storage and transfer in major countries. Project management skills with ability to identify risks and issues, and propose appropriate measures as required Ability to work independently and collaboratively in a fast-paced, matrixed, team environment consisting of internal and external team members. Analytical thinker with problem-solving skills and the ability to adapt to changing priorities and deadlines. Excellent verbal and written communication skills. Planning, organization and time management skills including the ability to support and prioritize multiple projects. Accountable for executing decisions made within the function. Collaborates with cross-functional partners as needed to support team objectives and ensure alignment with broader program activities. Flexibility to travel domestically and internationally as required (~10%). Experience with Investigational New Drug applications (INDs) and New Drug Applications (NDAs) submissions, EU and Asia filing experience a plus. Proficiency with Microsoft Office The base range for this role at the Manager level is $150,000 - $178,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp; #LI-RM1 &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives. Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at&nbsp;www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice&nbsp;CA Privacy Notice

Manager, Biosample Operations

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.Reporting to the Regional Business Director, the Oncology Account Manager (OAM) will contribute to Kura’s overall sales objective by performing assigned sales related activities. The OAM will provide physicians, pharmacists, nurses and all healthcare professionals (HCPs) with product, services and approved information that will enable the HCPs to appropriately prescribe Kura’s product(s)The OAM will compliantly and successfully implement Kura’s marketing strategies and corresponding tactics in order to achieve short-term and long-term objectives. The ideal candidate will be capable of managing the territory and administrative requirements in an efficient and effective manner and will achieve full compliance with drug laws and regulations when representing Kura and Kura’s products to Healthcare Providers.&nbsp; ESSENTIAL JOB FUNCTIONS: Achieve the assigned sales objective for the territory Attain the designated goals for calls on appropriate healthcare professionals to communicate balanced, accurate, and complete information on Kura’s FDA approved products Develops and implements a territory business plan to meet customer needs and achieve goals Navigate through complex external/customer organizational structures including hospitals, IDNs, GPOs and healthcare communities while aligning with cross-functional commercial partners Demonstrate completion of administrative requirements including budget management, expense reports management, CRM call reporting and synchronization, etc. within timelines and company guidelines Demonstrates a deep understanding of healthcare professionals (HCP) and account needs, effectively utilizing this knowledge to strategically promote and expand the use of assigned products Operate the territory within the assigned expense budget and demonstrates fiscal responsibility Comply with all federal/state/local laws, regulations and guidelines including but not limited to the PhRMA Code on Interactions with Healthcare Professionals as well as complying with all Kura standards and policies relating to all job activities Successful completion and ongoing updates of all aspects of training including but not limited to product knowledge, disease state, market, selling skills and compliance Assists in the identification and resolution of issues and opportunities while communicating proactively to marketing and sales management Develops and consistently demonstrates an expert understanding of HCP and Account needs to appropriately expand use of assigned product.&nbsp; JOB SPECIFICATIONS: Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration 6+ years of successful pharmaceutical/biotech sales experience with 3+ in the oncology/hematology and/or rare disease markets, preferably with oral therapeutic selling experience Management of large territories that includes periodic overnight travel Occasionally work evenings and weekends as needed for conferences Excellent written and oral communication skills Strong computer skills, notably WORD, EXCEL and POWER POINT The base range for this role is $205,000 to $230,000 per year with a target IC of 60k. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. &nbsp;Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives. Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at&nbsp;www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice&nbsp;CA Privacy Notice

Oncology Account Manager - Minneapolis

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.ESSENTIAL JOB FUNCTIONS: Prepare monthly/quarterly journal entries for prepaids, depreciation of fixed assets, capitalized software, and commercial and G&amp;A accruals. Prepare monthly reconciliations for various accounts, including but not limited to bank reconciliations, prepaids, fixed assets, long-term assets, G&amp;A and commercial accrued contracts, software capitalization, etc. Collaborate with business owners and functional leaders to obtain contracts and project progress and information to ensure timely and accurate accruals. Analyze contracts and collaborate with functional owners to appropriately capture capitalized software and fixed assets. Prepare monthly and quarterly variance analyses for various accounts and projects. Perform monthly close activities such as preparing monthly trial balance and reporting. Review invoice and purchase order coding for assigned departments. Prepare and submit property tax filing for various locations and ad hoc reporting. Ensure accuracy and compliance with GAAP and Sarbanes Oxley policy and procedures. Support financial and SOX reviews and audits - gather information, prepare schedules as needed. Responsible for quarterly related party updates and support, including related party inquiries, related party memo update, and transactional JE’s and analysis. Responsible for overseeing and reviewing the R&amp;D by location reporting for taxes and census reporting. Perform other duties and ad hoc projects, as assigned, to support the Finance department. JOB SPECIFICATIONS: Bachelor’s degree in accounting, or other related discipline, or the equivalent knowledge and experience required. A minimum of 5 years’ relevant accounting experience, preferably in a combination of the following monthly close process, bank reconciliations, balance sheet reconciliations, contract accruals Excellent communication and people skills and the ability to interface with various levels of co-workers, upper management, and external customers while maintaining a high degree of confidentiality. Experience working in publicly traded company and life science industry preferred. Knowledge of US GAAP and internal control principles for a public corporation. ERP experience required; experience with NetSuite, Blackline, Coupa and Concur preferred. Skilled in the use of Microsoft Office Suite with intermediate to advanced Excel skills. Detail oriented with good analytical skills. Strong time management skills and ability to independently organize multiple tasks of varying priorities and meet critical deadlines in a fast-paced environment. Ability to work in team environment and willing to assist other team members to achieve team goals and objectives. The base range for this role is $100,000 - $122,000. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus. #LI-RM1Kura’s Values that are used for candidate selection and performance assessments: We work as one for patients We are goal-focused and deliver with excellence We are science-driven courageous innovators We strive to bring out the best in each other and ourselves The Kura Package Career advancement/ development opportunities Competitive comp package Bonus 401K + Employer contributions Generous stock options ESPP Plan 20 days of PTO to start 18 Holidays&nbsp; (Including Summer &amp; Winter Break) Generous Benefits Package with a variety of plans available with a substantial employer match Paid Paternity/Maternity Leave In-Office Catered lunches Home Office Setup Lifestyle Spending Stipend Commuter Stipend (Boston Office) Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more! Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives. Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at&nbsp;www.kuraoncology.com&nbsp;and follow us on&nbsp;X&nbsp;and&nbsp;LinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.&nbsp; If you are a California resident, please see the attached Privacy Notice&nbsp;CA Privacy Notice

Dir/Senior Director, Trade & Patient Access Operations

Your career is worth investing in.

Get unlimited referrals with Premium.